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ABSTRACT
Solubility is a critical factor of protein-based drugs during processing and patient 
administration. This study focused on two aspects of solubility: one was the poly 
(ethylene) glycol (PEG) precipitation of monoclonal antibodies (mAbs) and another was 
crystallins aggregation that is associated with cataracts. Protein precipitation by PEG is a 
common technique for downstream processing. The effects of pH, ionic strength and the 
exclude volume effect on the protein precipitation by PEG were extensively studied, but 
the effects of glycosylation on protein precipitation by PEG has not been examined. 
Protein aggregation is not only a problem in downstream processing, but it is also related 
to some diseases. In 2015, lanosterol and 25-hydroxycholesterol were reported to 
dissolve protein aggregates in cataract lenses. Researchers focused on dissolution of lens 
protein aggregates, but the effects of those two sterols on the formation of aggregates 
were not investigated. The objectives of this dissertation were: 1) to determine the role of 
glycosylation in the precipitation of mAbs by PEG, and 2) to study the effects of 
lanosterol and 25-hydroxycholesterol on a-crystallin aggregation. The glycosylated mAbs 
showed higher solubility than non-glycosylated mAbs. It was found that available 
solubility models cannot correlate the effect of glycosylation. Lanosterol and 25- 
hydroxycholesterol failed to prevent a-crystallin aggregation. A concentration of 125pM 
of the two sterols promoted the aggregation of a-crystallin and of the a/y complex 
possible by serving as nucleation sites. The secondary and tertiary structures of a- 
crystallin were not affected upon addition of the two sterols. The a-crystallin chaperon 
activity and the capacity of binding with Cu2+ were not affected either.
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1. INTRODUCTION
With the development of recombinant technology, the commercial production of 
medicinal protein preparations became a reality. The preparation of a protein as a 
pharmaceutical drug became an indispensable part of the pharmaceutical industry. 
However, the solubility of proteins during processing and storage affected its medical and 
commercial applications. Proteins are the final product of DNA translation. Proteins 
serve as enzymes, carriers of cell signaling and ligand binding, and are structural 
components. Each protein has distinctive structures that support their biological 
functions. The protein solubility is a determining factor for their biological functions.
For example, keratin is a type of insoluble protein that is the structural material for hair 
and nails[1]; crystallins require high solubility to maintain eye lens transparency.[2] 
Protein aggregation is a consequence of soluble protein molecules forming insoluble 
aggregate. Undesired protein aggregates lead to diseases like cataracts.
In this dissertation, protein solubility was studied from two different 
perspectives. One was the poly (ethylene) glycol (PEG) precipitation of monoclonal 
antibodies (mAbs) and the other was the effects of lanosterol and 25-hydoxycholesterol 
on the a-crystallin aggregation processes.
1.1. PROTEIN STUCTURE
Proteins have four levels of organization that makes each protein type unique. The 
primary structure of a protein refers to the amino acid sequence that forms the peptide 
chain; i.e. the sequence of amino acid residues in the protein molecule, including their
number, type and sequence. Amino acids are connected to each other by peptide bonds, 
i.e. a molecule of water is removed between the a-amino group of one amino acid and the 
a-carboxyl group of another amino acid. Peptide bonds have the properties of partial 
double bonds, so the entire peptide unit is a rigid planar structure. The end of the 
polypeptide chain containing a free amino group is called the N-terminus of the peptide 
chain, and the end containing a free carboxyl group at the other end is called the C- 
terminus of the peptide chain. Changes in the primary structure of a protein can change 
its secondary structure and its function.[3]
Secondary structure refers to the structure formed by the folding of the 
polypeptide chain backbone. The most basic types of secondary structure are a-helical 
and P-sheet structures; both structures are maintained by hydrogen bonds. There are also 
P-turns and random coils. Each peptide bond in the helix is involved in the formation of 
hydrogen bonds to maintain the stability of the spiral. P-sheet structures are also 
common. In this structure, the polypeptide chain exists in a relatively stretched form, and 
the arrangement of the peptide chains (or peptide segments) can be parallel or 
antiparallel. The axial distance between amino acids is 0.35 nm, and adjacent peptide 
chains are connected to each other by hydrogen bonds to form a layered structure.[4]
The tertiary structure of a protein is the three-dimensional shape of the entire 
polypeptide chain formed by further folding and rolling of secondary structures. Amino 
acids interact with one another via charge-charge, hydrophobic, disulfide, or other 
interactions. The polypeptide chains of rhe protein are coiled and folded in multiple 
directions in a three-dimensional space to form a tight, approximately spherical structure. 
The space inside the molecule can only accommodate a few water molecules. Almost all
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polar side chains are distributed on the outer surface of the molecule to form a 
hydrophilic shell, while most non-polar side chains are buried inside the molecule and do 
not contact water. The interaction of side chain in protein molecules plays an important 
role in stabilizing the tertiary structure of proteins.[5]
The quaternary structure refers to the structure of a protein formed by interactions 
between multiple polypeptide chains. In a protein with a quaternary structure, each 
peptide chain with a tertiary structure is called a subunit. The absence of a subunit makes 
the protein biologically inactive. The quaternary structure involves the spatial 
arrangement of subunits in the entire molecule and the relationship between subunits.[6]
1.2. PROTEIN SOLUBILITY
The solubility of a protein is affected by changes in pH, temperature, ionic 
strength, the addition of cosolvents[7], and by post-translational modifications like 
glycosylation. Each of these environmental factors directly affects protein solubility. The 
pH and ionic strength both affect the net charge of protein. A few amino acids are weak 
acids and basis; therefore, proteins normally bear a net charge. At the pH equal to the 
isoelectric point (pI) of a protein, the protein molecules exist in the form of zwitterions, 
and their net molecular charge is zero (that is, the positive and negative charges are 
equal). At pHs below or above the pI, the protein is positive-charged or negative-charged 
respectively. For a pH near the pI, protein’s solubility is at a minimum because the 
electrostatic repulsive force was minimized.[8] When the force is weakened, 
intermolecular collisions lead to aggregates that eventually precipitate. Therefore, when 
the pH of a protein solution is at the pI, the protein solubility is the lowest and a
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precipitate is most likely to form. Many physical properties at the pI, such as viscosity, 
swelling, and osmotic pressure are reduced, which is beneficial to the filtration of the 
suspension.[9] The effects of ionic strength on the protein solubility depend on pH. 
Briefly, at a pH near pI the addition of salt to a protein solution first increases (salting-in) 
and then decreases (salting out) protein solubility. At pHs below or above pI, the addition 
of salt first decreases protein solubility by screening electrostatic repulsions and then it 
raises protein solubility due to 1) the interaction between weakly hydrated monovalent 
anions and polar and nonpolar groups on the protein surface; 2) the interaction between 
amide bond and multivalent cation.[10]
The solubility of a native protein also decreases as the temperature decreases. An 
increase in temperature unfolds the protein; therefore, it induces the formation of 
aggregates that eventually precipitate. High temperatures not only affect the secondary 
structure of a protein, but also, in some cases, it alters the quaternary structure of a 
protein oligomer, i.e. the a-crystallin that belong to the small heat shock protein form 
larger oligomers at temperatures higher than 37oC.
Dehydration of a protein is the main mechanism for protein destabilization caused 
by the addition of cosolvents. Protein precipitation by alcohols has a long history. The 
alcohols disrupt the hydration shell of protein that leads to aggregation and precipitation. 
To prevent irreversible protein aggregation, alcohol precipitation is usually conducted at 
4 oC.
Non-ionic polymers include dextran and poly (ethylene) glycol (PEG) were used 
to precipitate proteins. This phenomenon were explained by exclude volume theory that 
was first introduced by Asakura and Oosawa.[11] The non-ionic polymer molecules were
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excluded from the volume between two protein molecules, then the volume between two 
protein molecules becomes a phase of pure solvent; therefore, the particular distribution 
of the polymer causes a pressure imbalance that pushes the proteins against each other, 
known as the exclude volume theory. PEG precipitation has been used, for example, for 
the crystallization of glycosylated and non-glycosylated variants of agglutinin, extraction 
of chicken IgY from egg yolk[12], precipitation of lysozyme[13], and coupled with 
chromatography to purify botulinum neurotoxin type B, among other uses.[14]
Post-translational modifications also affects protein solubility. Common post­
translational modifications include: acylation, acetylation, alkylation, glycosylation 
etc. [15] Glycosylation consists of the addition of various glycan groups to the 
polypeptide chain.[16] Glycosylation may protect proteins from stresses that destabilize 
them, such as precipitants, pH, chemicals, and heat.[17] Aggregation is a known 
phenomenon observed in commercial antibodies preparations (particularly after 
reconstituting a freeze-dried sample).[18] The formation of biologically inactive 
aggregates decreases their efficacy. Moreover, there is evidence that protein aggregates 
present in a protein drug increase immunogenicity.[19, 20] It was argued that 
glycosylation increased the stability of the protein; therefore, it was expected that a non- 
glycosylated antibody was more susceptible to aggregation.[21]
Precipitation is an important downstream processing step. Precipitants are used to 
lower protein solubility and induce protein solid-liquid or liquid-liquid phase-separation 
to separate proteins from undesired impurities. Salts, organic solvents, and non-ionic 
polymers (PEG and dextran) are frequently used precipitants. One of the advantages to 
used PEG is that it precipitates proteins without. pH, ionic strength, and temperature are
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critical factors in PEG precipitation,[22-24]and they were extensively studied as evident 
in previous related literature. Depletion and electrostatic forces control the extent of 
protein precipitation by PEG. However, the role of glycosylation is unclear, creating a 
gap in the literature.
In paper I, glycosylated and non-glycosylated mAbs were selected as models to 
study the effect of glycosylation on protein precipitation by PEG. PEG 1450 Da and 8000 
Da were used. The effects of pH and temperature were also explored. Additional studies 
were performed in the presence of a Griffonia (Bandeiraea) simplicifolia Lectin II (GSL- 
II), which binds to glycosylated proteins. The precipitation curves were fitted with a 
Cohn salting-out equation analogous. The PEG precipitation efficiency coefficient, which 
was extracted from the curve fitting, was compared to the available solubility models.
This study’s data showed that glycosylation enhanced the mAbs solubility in the presence 
of PEG.
1.3. DISSOLUTION OF CATARACTS BY THE ADDITION OF STEROLS
Mammals’ eye lenses have onion-like layered structures. The outward facing edge 
of the lens consists of a mono-layer of epithelial cells that differentiate to new fiber cells 
during the development of lens over the lifetime of an individual.[25] In order to 
maintain the transparency of the lens, the fiber cells lack of blood vessels and the sub­
cellular structures. The lenses’ high refractive index is caused by the high concentration 
of crystallins expressed in fiber cells, which require high solubility of crystallins. 
Conversely, lens fiber cells lack the capacity for protein turnover and repair.[26] The 
degradation of crystallins accumulate over a lifetime and thus their solubility decreases.
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The low solubility of aged crystallins results in aggregation, and they finally increase the 
scattering of light and form cataracts.[27, 28]
Cataracts cause approximately 50% of blindness worldwide.[29] Cataract surgery 
is readily available in the developed world, but it is less common in underdeveloped 
countries. Surgery is invasive and requires relatively sophisticated equipment; 
additionally, well-trained physicians are scarce in the underdeveloped world. Moreover, 
surgeries are almost nonexistent in large underprivileged populations in Asia, Africa, and 
the Middle East as well as in Central and South America. Curing cataracts using eye 
drops is a very attractive and financially sound alternative.
Zhao et al.[30] discovered that lanosterol (a triterpenoid and a precursor of 
cholesterol that accumulates in the eye lenses) can dissolve congenital cataracts in rabbits 
and dogs. Their work was inspired by the observation that a population with congenital 
cataracts was deficient in the enzyme that participates in one of the synthesis steps of 
lanosterol. A year later, Shanmugam et al.[31] tested lanosterol for the solubilization of 
age-related cataracts in humans; however, they observed that the triterpenoid (used in the 
dosage and protocol used by Zhao et al. to treat congenital cataracts) was inefficient in 
the solubilization of senile cataracts. At the same time, Makley et al.[32] used differential 
scanning calorimetry to determine the effect of approximately 2,500 compounds on the 
melting temperature of the model heat shock protein Hsp27, which is similar to the aB- 
crystallin. A promising set of 32 sterols was checked for their binding capabilities to a 
mutant of the aB-crystallin (R120G aB-crystallin). This mutation of aB-crystallin was 
known to destabilize proteins in the lenses. Makley et al. also found that the most 
promising compound (25-hydroxylcholesterol) increased transparency in mouse model
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cataracts. This 25-hydroxylcholesterol compound was bound to R120G aB-crystallin and 
lowered its melting temperature (the temperature at which the protein unfolds). They 
concluded that lanosterol was not a good candidate because of its low solubility and 
marginal effect on the melting temperature of Hsp27; therefore, it was not included in the 
final set of 32 sterols. These observations started a new chapter in cataract research.[33] 
Following the studies of lanosterol and 25-hydroxycholesterol to restore lens’ 
transparency, other researchers tried to repeat those experiments or collect additional 
experimental evidence about the activity of those sterols. Shen et.al. [34] found that, in 
vitro, lanosterol (40 pM in M199 medium) delayed the occurrence of lens opacity in a 
lanosterol synthase inhibited rat lens. Xu et.al.[35] used 20 pM lanosterol in 1% DMSO 
to successfully reverse W151R mutant human pB2-crystallin aggregates. Kang et al. [36] 
used all atom molecular dynamics simulation and free energy perturbation techniques to 
show that lanosterol can bind to the hydrophobic interface of dimers of human yD- 
crystallin preventing aggregation. Daszynski et al.[37] failed to repeat the experiments by 
Zhao et al.[30] and Markley et al[32] using their same approach. Also Daszynkski et 
al.’s docking simulations shows those two sterols cannot bind to the groove which is 
formed by the a-crystallin dimer using two wild types (PDB 2WJ7 and 2KLR) and a 
R120G mutant (PDB 2Y1Z) aB-crystallin. Nagai et.al.[38, 39] used lanosterol 
nanoparticles with a particle size distribution from 50 to 400 nm to repair the space and 
structural collapse in the early stages in the lenses. They found that it delays the onset of 
opacification of the lenses with a remarkable lens structure collapse and opacification, 
but it does not repair them. They speculated that the repeated injection of lanosterol
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nanoparticles attenuated the manifestation of cataract-related factors and perhaps protects 
the lenses from oxidative stresses.
A plausible explanation for the restoration of transparency in the lenses is the 
fitting of lanosterol and 25-hydroxycholesterol into the interface of crystallin dimers. 
Makley et al. [32] and Daszynski et al. [37] studied the possible interactions between 25- 
hydroxycholesterol or lanosterol and the a-crystallin dimer interface by docking 
simulations. Both of them predicted the Kd (dissociation constant that is the ligand 
concentration at which half the protein molecules will have a ligand bound) of the two 
sterols were in the high micromolar or even millimolar range; i.e. Kd values for 
lanosterol-2KLR (wildtype aB-crystallin) and 25-hydroxycholesterol dimer interface 
were 73.63 mM 25-hydroxycholesterol and 1.22 mM, respectively.[37] Daszynski et 
al. [37] concluded that this high concentration of the two sterols could not be achieved 
clinically in the lens.
a-crystallin exists in the lenses as a multimeric aggregate.[40] The aggregates 
dissolve when stressed (a-crystallin is a member of the small heat shock protein’s family) 
releasing dimeric aA-crystallins (aA-crystallin and aB-crystallin) that stabilize other 
proteins, such as P- and y-crystallins,[41] in the lenses. Members of the sHsp are found 
in all forms of life and have a highly conserved a-crystallin domain structure across 
species. The sHsps are molecular chaperones that bind to unfolded or partially unfolded 
proteins, preventing their interaction with other unstable proteins. Unfortunately, the 
effect of sterols on the a-crystallin chaperone activity is not investigated.
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Evidence of cataract lens restoration only occurred in animals (dogs and rabbits). 
The ineffectiveness in restoring human cataracts is the limitation of lanosterol solubility 
in the delivery medium. Mixed solvents showed the ability to enhance lanosterol 
solubility. The solubility of lanosterol is not reported in the open literature. A lanosterol 
product datasheet from Cayman Chemical Company[42] reported that the lanosterol 
solubility in ethanol and N,N-dimethylformamide (DMF) are 0.25mg/mL and 3 mg/mL, 
respectively, but the temperature was not specified. Zhao et al. used 10-40 pM of 
lanosterol in 1% DMSO that may contain undissolved lanosterol particles, which raises a 
question that the crystallins aggregates interact with dissolved lanosterol or the 
undissolved ones. . Access to solubility data for lanosterol is critical for its use to restore 
crystallin aggregates, and it is also important for patient administration, especially 
through eye drops.
In paper II, lanosterol solubility in organic solvent and water-alcohol binary 
systems was measured first. A lab-built experiment set-up was used to measure lanosterol 
solubility at different temperatures. It was found that lanosterol solubility increased with 
increased temperatures, and it increased with increasing alcohol content. Lanosterol has 
a low solubility in water at approximately 0.5 pM at 25oC and increased little with 
increasing temperatures. The melting temperature and enthalpy of fusion for lanosterol 
was also measured. Powder X-Ray diffraction (PXRD) was employed to monitor the 
crystal form of the undissolved lanosterol. We demonstrated that aqueous solutions that 
contained more than 0.5 pM lanosterol had undissolved lanosterol particles.
After collecting the lanosterol solubility data, a series of experiments were 
performed using lanosterol,25-hydroxycholesterol and crystallins. Following the studies
of lanosterol and 25-hydroxycholesterol, other researchers tried to repeat those 
experiments and to study the mechanism of the restoration ability of the two sterols. The 
effects of lanosterol and 25-hydroxycholesterol on the a-crystallin aggregation process 
were not investigated in the available literature. If the compounds cannot inhibit protein 
aggregation, they cannot solubilize aggregates. Furthermore, the influence of the two 
sterols on the a-crystallin critical biological function and the chaperone activity were not 
covered in previous researchers’ work.
In paper III, a series of experiments were conducted using bovine crystallins 
isolated from raw bovine lenses. The aggregation kinetics of a-crystallin incubated with 
lanosterol and 25-hydroxycholesterol with a concentration of 125 pM or lanosterol at 0.5 
pM and of 25-hydroxycholesterol at 45 pM at 55oC were monitored by turbidity, high 
performance liquid chromatography (HPLC), and Fourier-transform infrared 
spectroscopy (FTIR). Then the chaperone activity of a-crystallin using y-crystallin as 
substrates in the presence of those two sterols was evaluated using the same methods, but 
the temperature was lowered to 50oC. The a-crystallin binding capacities of Cu2+ were 
measured by the PAR colorimetric method and the bis-ANS fluorescence assay. Those 
two sterols failed to prevent a-crystallin aggregation and could not enhance a-crystallin 
chaperone activity regardless of concentration. FTIR and Circular dichroism (CD) results 
showed that the secondary and tertiary structures of a-crystallin were not affected by the 





I. POLY (ETHYLENE) GLYCOL (PEG) PRECIPITATION OF 
GLYCOSYLATED AND NON-GLYCOSYLATED MONOCLONAL
ANTIBODIES
ABSTRACT
The solubility of monoclonal antibodies (mAb) affects their production and their 
intravenous administration to patients. In this work, the solubility of a fully glycosylated 
and a non-glycosylated human mAb expressed in corn was studied by inducing their 
precipitation by adding poly(ethylene) glycol (PEG). The experiments were done using 
PEG 1,450 and 8,000 at concentrations ranging from 0 to 30 % w/w, at different pHs and 
temperatures. Additional studies were performed in the presence of a Griffonia 
(Bandeiraea) simplicifolia Lectin II, which binds to glycosylated proteins. These studies 
clearly show that glycosylation increases the solubility of the antibody. These studies 
also show that models based on excluded volume principles or on the statistical 
correlation of solubilities are unable to capture the effect of glycosylation on protein 
precipitation by PEG.
1. INTRODUCTION
In the past decades, monoclonal antibody (mAb) and mAb fragment-based drugs 
have drawn great attention in the pharmaceutical industry because of their high target 
specificity and therapeutic efficacy.[1] mAbs are glycoproteins, the glycan groups help
conserving the structure and function of the antibody. [2] Also the different types of 
glycan groups make antibodies very heterogeneous. Moreover, the glycan groups affect 
the immunological properties of antibodies by altering their affinity for Fc receptors.[3] 
Antibodies glycosylated in vitro or in transgenic plants show greater diversity than their 
in vivo counterpart and this diversity may differ from batch to batch, which causes some 
batches not meeting specifications. A straightforward approach to eliminate this problem 
is to shut down the glycosylation machinery altogether. Although the heterogeneity 
problem is of course eliminated, the fact that the native and the non-glycosylated 
antibodies are not exactly the same (in spite of both having the same biological activity) 
raises questions about the solution stability (solubility) of the non-glycosylated 
antibody.[4, 5]
Glycosylation may protect proteins from stresses that destabilize them such as 
precipitants,[6-8] pH,[9, 10] chemicals,[11, 12] and heat.[10, 13] Destabilization of the 
protein may lead to aggregation, which is a known phenomenon observed in commercial 
antibodies preparations [14, 15] (particularly after reconstituting a freeze-dried sample). 
The formation of biologically inactive aggregates decreases the solubility of the 
preparation impeding their normal function. Moreover, there is evidence that protein 
aggregates present in a protein drug may increase immunogenicity.[16] Because it has 
been argued that glycosylation increases the stability of the protein, it is expected that a 
non-glycosylated antibody will be more susceptible to aggregation.[3]
Proteins may be precipitated by manipulating the pH, temperature, ionic strength, 
and the chemical composition of the solution.[17] Non-ionic polymers such as dextran 
and poly(ethylene)glycol (PEG) can also be used to precipitate proteins.[18, 19] PEG is
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more effective than dextran[20] and the precipitation effectiveness increases with an 
increase in the size of PEG; however, solutions containing high molecular weight PEG 
(>10,000) are so viscous that they are not practical to use.[21]
PEG precipitation has been used, for example, for the crystallization of 
glycosylated and non-glycosylated variants of agglutinin,[22] extraction of chicken IgY 
from egg yolk,[23] precipitation of lysozyme,[24] and coupled with chromatography to 
purify botulinum neurotoxin type B[25] among many other uses. In addition, PEG 
precipitation has been used as a screening tool for developing high protein concentration 
formulations.[26] Recently, a new method of continuous PEG precipitation followed by 
tangential flow filtration was developed.[27] Such a method may be used to replace the 
costly chromatography method (mostly Protein A based) in the downstream processes of 
mAbs.
Two arguments have been used to explain the mechanism of protein precipitation 
by non-ionic-polymers. The simplest one consists of considering that the presence of the 
polymer decreases the volume of the solution available to the protein. This would force 
the proteins to be closer to each other such as precipitate nuclei would form. The second 
argument consists of considering that because of steric constraints the polymers are 
excluded from the space separating two protein molecules. This particular distribution of 
the polymer causes a “pressure imbalance” that pushes the proteins against each other. 
Purely stearic arguments (argument 1) fail to explain the effect of the protein charge on 
protein precipitation by non-ionic polymers. On the contrary, the second argument can 
nicely (and rigorously) incorporate the effect of pH on protein precipitation by non-ionic 
polymers.[18] Because both approaches assume that the solvent is a continuous fluid,
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they cannot capture the contribution of hydration forces to protein stability. For example, 
water of hydration enters into Mahadevan-Hall’s[28] model as a contribution to the 
volume of the molecule. The consequence of that is that the more hydrated the protein is 
the more prone to precipitation it will be, which does not agree with experimental 
evidence.
In this paper, the precipitation by the addition of PEG of a monoclonal antibody 
expressed in corn was studied. Glycosylated and non-glycosylated samples of the same 
antibody were used. The experimental parameters were PEG concentration and molecular 
weight, pH and temperature. A few experiments were done with the addition of Griffonia 
(Bandeiraea) simplicifolia Lectin II (GSL-II), which is a lectin[29] specific to the 
GlcNAc group that is present in the corn-expressed antibody. The solubility data were 
fitted with a Cohn[30, 31] salting-out equation analogous, and selected experiments were 
compared with the theoretical models from Sim et al. ,[32] Odijk[33] and Atha and 
Ingham.[18]
2. MATERIALS AND METHODS
2.1. GLYCOSYLATED MIXTURE AND NON-GLYCOSYLATED MAB
The mAbs were generously supplied by Monsanto Protein Technologies (St. 
Louis, MO) or extracted from recombinant corn flour according to the procedure 
described in Lee and Forciniti[34] and purified using a Protein A column. GSL-II, and 
PEG of 8000 and 1450 Da were purchased from Sigma (St. Louis, MO). All the other 
chemicals were of analytical grade. Two protein preparations were used: 1) a fully non-
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glycosylated mAb (we refer to this preparation as non-glycosylated) and 2) a mixture of 
25% non-glycosylated, 50% single GlcNAc glycosylated mAb, and 25 % fully 
glycosylated mAb (we refer to this preparation as glycosylated mixture).
2.2. PRECIPITATION EXPERIMENTS
0.31g of the glycosylated mixture or 0.61g of the non-glycosylated protein mAb 
(or a total of 1.27mg each protein) were mixed in a centrifuge tube with various amounts 
of a PEG stock solution (50% w/w of either PEG 1450 or PEG 8000) and phosphate 
buffer at pH 6, TRIS buffer at pH 9, acetate buffer at pH 4, or carbonate-bicarbonate 
buffer at pH 10.7 to complete 2.5 g. GSL II was added to some systems at a concentration 
(in moles) similar to that of the mAb. The contents of the tubes were mixed in an orbital 
mixer for 20 minutes and then centrifuged at either 4 °C, 25 °C, or 40 °C for 90 minutes 
at 2,800 xg. Samples of the supernatant were removed and absorbance at 280 nm was 
measured in a double beam spectrophotometer. Appropriate blanks were prepared each 
time and their absorbance values were discounted from the samples’ reading. For the 
systems containing lectins, the precipitate was re-suspended in the appropriate buffer and 
run through a gel permeation column using a UV detector in tandem with the MALS 
detector.
2.3. MULTIPLE ANGLE LASER LIGHT SCATTERING (MALS)
Samples of the glycosylated and non-glycosylated mAb were injected through a 
50 pL or a 250 pL loop into a gel permeation column (Protein KW-803, Shodex). Two 
detectors were connected in series: 1) a Hitachi UV spectrophotometer and 2) a Wyatt
multiple angle laser light scattering detector. The flow rate was either 1 ml/min or 0.5 
ml/min. The same procedure was followed with re-suspended precipitates of the 
antibodies in the presence of lectins.
The extinction coefficients of the glycosylated and non-glycosylated mAbs were 
determined as e= 1.37 cm2/mg and s = 1.15 cm2/mg, respectively.[34] The molecular 
weight of the proteins was determined by the Debye plotting of the scattering data using 
an internal calibration constant for the UV detector.
2.4. EXPERIMENTAL DESIGN
A full two-level experimental design was used. The factors included pH (6 and 9), 
glycosylation of the mAb (glycosylated and non-glycosylated) and PEG molecular 
weight (8,000 and 1450). Additional experiments were performed at 5, 25 and 40 oC and 
in the presence of GSL-II.
2.5. THEORETICAL BACKGROUND
A semi-logarithmic analogous to the Cohn salting-out equation was suggested by 
Juckes[31] to correlate protein solubility with PEG concentration,
log S = p<a + K (1)
where S is protein solubility, rn is the PEG concentration in % w/w, and k is the log of the 
intrinsic solubility of the protein in the absence of PEG. The ̂ -value that represents the 




Differentiating Eq. 1 with respect to the polymer concentration yields,
d  log S = A log S = (2 )
d a  Aa
Using the depletion theory of nanoparticles immersed in a semi dilute polymer 
solution, Odijk[33] derived an expression for p  in terms of hydrodynamic radius of the
protein (rh.prot),
A log S 
Aa
= P = -0.036rth, p r o t (3)
Another model for p  was proposed by Atha and Ingham.[18] Their model is based 




where M2 is the molecular weight of PEG, and a is the interaction coefficient between 
protein and polymer, which can be calculated by the expression of molar excluded 
covolume for pairs of spherical molecules 2-3 as proposed by Ogston,[35]
U 23 =  1 0 3  =
4 n N
( r h,^  ,p r o t  ‘ h ,P E G
)3 (5)
where U23 is the molar excluded covolume for pairs of spherical molecules 2-3, N is 
Avogadro’s number, and rh,PEG is the hydrodynamic radius of PEG.
Based on previous works,[18, 33, 36-38] Sim et al. [32] proposed a model for p 
that includes the hydrodynamic radius of protein (rhprot) and PEG (rh,PEG),
P  =  rhJPEG + $ ) rh,prot (6)
where y and S are regression parameters. The first term (yrlPEa rh,prot) was interpreted by 
Sim et al. as the depletion of protein by PEG whereas the second term (5 rh,prot) accounts
for the volume excluded by the protein and the depletion of PEG by the protein. This 
depletion of PEG by protein allows the protein to remain soluble. They regressed data for 
6 different proteins with PEGs of three molecular weights at each protein’s isoelectric 
point.[39] Regression of the experimental data sets yielded the following correlation for 
(  with the radius of the polymer and the protein,[39]
A = (0.076S  -  0.045)rhprot. (7)
The regression was not very good as evidenced by a correlation coefficient of 
R2=0.725. Compared to Atha and Ingham’s model, Sim’s model is a simple correlation 
for protein solubility with PEG and protein sizes, but it is based on fundamental 
principles of polymer physics.
All three models need the hydrodynamic radius of protein (rh,prot) and PEG 
(rh,PEG) to calculate the (-value. In this study the rh,PEG was calculated using the 
correlation by Fee et a/.,[36]
rKpEG = 0.1912MPEG (8)
The rh,prot of both proteins was determined using the molecular weights obtained 
from the MALS results assuming globular proteins (molecular weight: 150 kDa and
rh,prot= 5.3 nm).
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3. RESULTS AND DISCUSSION
We first determined the precipitation of the mAb solutions in the absence of PEG. 
Measurements of protein concentration after centrifugation of the standard solutions were 
done after 20 min., 2.5, 12, 24, and 36 hours for selected systems (pH 4, pH 6, pH 10.7,
and pH 6 with GSL II) in the absence of PEG. The decrease in the solubility of the 
glycosylated sample was between 0.1 to 7% after 36 hrs. On the contrary, the decrease in 
the solubility of the non-glycosylated mAb ranged from 0.1% (pH 6 plus GSL II) to 40 % 
(pH 10) also after 36 hrs. The presence of the lectin seems to stabilize the non- 
glycosylated mAb. The isoelectric point of the non-glycosylated mAb is from 9.7 to 9.1 
whereas the isoelectric point of the glycosylated mixture expands the range from 9.4 to 
8.7[34, 40]. Near its isoelectric point, the non-glycosylated mAb solution becomes quite 
unstable after 24 hours. The experiments containing PEG were done using an incubation 
time of 20 minutes.
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Figure 1. Effect of PEG molecular weight, pH and temperature on the solubility of mAbs. 
‘G’ or ‘NG’ represent glycosylated mixture and non-glycosylated mAbs in the legend and 
marks ^  is the onset precipitation concentration of PEG. Panel A. effect of PEG 
molecular weight. Panel B, pH effect in PEG 8000. Panel C, effect of pH at PEG 1450. 
Panel D, effect of pH at pHs which are more away from pIs. Panel E and F, effect of
temperature
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Figure 2. Effect of Griffonia (Bandeiraea) simplicifolia Lectin II (GSL II) on the 
solubility of mAbs upon addition of PEG 8000. The dashed lines are used to show a two- 
step precipitation process. Panel A: pH 4. Panel B: pH 6. Panel C: pH 10.7
Plots of antibody solubility vs. polymer concentration at different conditions are 
shown in Figures 1 and 2. “G” and “NG” in the figures represent the glycosylated 
mixture and the non-glycosylated mAb, respectively. Figure 1 shows the effect of pH, 
PEG molecular weight and temperature and Figure 2 shows the effect of the addition of a 
lectin on the solubility of the mAbs. Figure 1A shows that both preparations are more 
soluble in PEG 1450 than PEG 8000. Both preparations are more soluble at pH 6 than 9 
in the presence of either PEG 1450 or PEG 8000. At very acidic (pH 4) or very basic (pH 
10.7) pHs the solubility of both preparations increases but the solubility of the 
glycosylated mAb is more sensitive to pH changes. The results obtained at pH 10.7 are
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striking since the glycosylated mAb does not precipitate in the PEG concentration range 
covered by these experiments, in spite of the fact of containing 25% of the non- 
glycosylated protein. At the highest PEG concentration used to precipitate the non- 
glycosylated mAb (24% w/w) approximately 25% of the antibody remains in solution; 
which may explain the absence of precipitation at pH 10.7. Figure 1E and F show the 
effect of temperature on the solubility of the mAb in the presence of PEG. At 4°C and at 
a PEG concentration of 12% only 1% of the non-glycosylated mAb remains in solution 
whereas about 8% of the glycosylated mixture remains in solution at the same conditions. 
Finally, Figure 3 shows that the precipitation of the mAbs in the presence of a lectin 
follows a two-step process at pH 4 and 6. The precipitation curves were fitted with a 
Cohn salting-out equation analogous (Eq.1) to obtain the precipitation efficiency 
coefficient, fi. The m*-values (the PEG concentration at the onset of precipitation) where 
calculated from the intercept of the Cohn equation with a horizontal line at the initial 
protein concentration.
3.1. m* VALUES
The m* values for all runs are shown in Table 1 and in Figure 3. Figure 3A 
shows that, with a few exceptions, the value of m* is larger for the glycosylated than for 
the non-glycosylated mAb. The difference in the m*-value of the glycosylated mixture 
and non-glycosylated mAb is more pronounced at pH 4 and PEG 8000 (Figure 3B and 
C). This confirms that one of the roles played by the carbohydrates chains is to increase 
protein solubility. The m*-values of both preparations decrease as the temperature 
decreases as expected.
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Table 1. m*-values and ̂ -values of glycosylated mAb mixture and non-glycosylated
MAb precipitation curves
PEG/Da pH T/oC Additive Glycosylated mixture Non-Glycosylated MAb
P-value m*-value P-value m*-value
1450 6 25 N/A -0.16±0.008 22.4640.2 -0.3140.02 21.640.2
1450 9 25 N/A -0.14±0.007 14.140.1
8000 4 25 N/A -0.20 ± 0.02
-0.2240.008 13.3140.1
8000 6 25 N/A -0.14 ± 0.01
18.840.8 -0.283 4 0.004 13.940.1
8000 9 25 N/A -0.12 ± 0.02
8.440.2
8.040.3




8000 10.7 25 N/A 0 N/A -0.19 4 0.02 15.340.9
8000 6 4 N/A -0.184 6.09 -0.429 7.78
8000 6 40 N/A -0.11 ± 0.02 8.640.4 -0.153 9.96
1st 2nd 1st 2nd 1st 2nd 1st 2nd




8000 6 25 GS -0.1 -0.2 4.5 7.1 -0.064 0.24 5.1 6.8L II 1 1 4
10. GS -0.034 9.08000 25 0 0 N/A N/A7 L II 4 0.009 40. N/A
To identify the main effects on the m*-values, a Paretto chart (Figure 3D) was 
constructed using three experimental factors: 1) type of mAb, 2) PEG molecular weight 
and 3) pH. The most significant factor is the molecular weight of PEG whereas the 
presence of the glycan groups is less statistically significant on the onset of precipitation. 
Recently, a quantitative structure-activity relationship (QSAR) [41] model was used to 
correlate the experimental m*-values and ̂ -values with 132 molecular descriptors. The 




Figure 3. m*-values.Panel A. Comparison of m*-values of both mAb preparations. 
Panels B (PEG Mw 8000) and C (PEG Mw1450). pH dependence of the m*-values; ■, 
glycosylated mAb; • , non-glycosylated mAb. Panel D. Paretto chart for m*-values. PEG 
molecular weights: 1450 or 8000Da, pHs: 4 or 6, and both types of mAbs. Panel E,
Effect of temperature on m*-value
That study paves the way to explain protein precipitation by PEG based on 
protein surface properties. The 10 molecular descriptors with highest variable of the 
influence on the projection (VIP) of m*-values are shown in Table 2 in decreasing order 
of importance. The direction of the influence of each factor on m*-value is given by the 
sign of the regression coefficient i.e., an increase in a molecular descriptor with a positive 
(+) regression coefficient will increase the amount of PEG per protein needed to start 
protein precipitation and vice versa. [41] They concluded that there are four major factors 
that can influence m*-values: the sphericity of the protein (-)> density of the protein (+)> 
electrostatic surface potential (ESP) (+)> solvent accessible surface area of protein (+). 
The ESP is easily manipulated by changing the pH of the solution. Still, there may be an
indirect effect of the carbohydrate chain on the ESP since its presence may affect the 
dissociation constant of ionizable amino acids side chains. The ESP of a protein will 
increase as the solution pH is farther away from the protein’s isoelectric point. Therefore, 
the amount of PEG needed to precipitate the protein will increase as the ESP increases, 
which agrees with our finding for both preparations with PEG 8000 and PEG 1450. The 
effect of pH for the whole design is somehow masked by the dominance of PEG 
molecular weight. The sphericity and density of the proteins barely change upon 
glycosylation. However, glycosylation does increase the solvent accessible surface area 
of protein.[42] Because the regression coefficient for solvent accessible surface area is 
positive and the glycosylated protein has a larger surface area, the onset of precipitation 
should happen at a higher PEG concentration for the glycosylated sample, as observed. 
However, the effect is not statistically significant at 95% confidence.
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Table 2. Descriptors with a VIP value >1.0 included in the final QSAR model for m*-
value and their descriptiona
Sign of
No. Descriptor Definition Regression
coefficient *123
shapeMin Value for the sphericity of the
protein:(minimum distance between
1 mass center and protein surface)/(mean -
distance between mass center and
protein surface)
2 dens Density of the protein +
sumSurfA_ShellEsp Sum of ESP of surface points projected
3 on a shell around the molecule with a +
distance of 5A
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Table 2. Descriptors with a VIP value >1.0 included in the final QSAR model for m*-






totalSurf_patchEsp Solvent-accessible surface area of 




toalSurfA_Shell Solvent-accessible surface area of a 
shell around the molecule with a 
distance of 5 A
+
6
totalSurf_PatchHyd Solvent-accessible surface area of the 
protein surface patch with the highest 
hydrophobicity value in A2
+
7 nAAcid Chain length of the protein +
8 mAtom Number of atoms of the protein +
9 mass Molecular mass of the molecule +
10
devA_PlaneEsp (maximum ESP value-minimum ESP 
value)/mean value of ESP on the plane 
with the highest ESP value
-
aReproduced with permission from reference 33
3.2. p-VALUES
The fi-values and associated errors of all runs are presented in Table 1 and plotted 
in Figure 4. The number of data points in some of the runs is too small and therefore 
errors in the fitting cannot be calculated. In all runs (even in the lectin containing runs) 
the fi-values are more negative for the non-glycosylated mAb than for the glycosylated 
mAb, which indicates that PEG is more efficient precipitating the non-glycosylated mAb. 
At the same pH, the higher the molecular weight of PEG the higher the efficiency to 
precipitate both the glycosylated and non-glycosylated mAbs. At the same PEG 
molecular weight, the efficiency decreases with increasing pH (Figure 4B and C). The fi-
values for the glycosylated mAb at pH 10.7 with the addition of PEG 8000 was set to 
zero because the glycosylated mAb cannot be precipitated in the PEG concentration 
studied. In the presence of PEG 8000 at pH 6, the efficiency increases with decreasing 
temperature for both samples (Figure 4E) but the solubility of the non-glycosylated mAb 
is more sensitive to changes in temperature than the glycosylated one(Figure 5E). For 
example, at 12% PEG, nearly 70% of the non-glycosylated protein remains in solution at 
40 oC whereas only 1% remains in solution at 4 oC.
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Figure 4. ^-values for the entire experimental base. Panel A, comparison of ̂ -values of 
the glycosylated and non-glycosylated mAb. ■ , glycosylated mAb; • , non-glycosylated 
mAb. Panels B (PEG 8000) and C (PEG 1450). ^-values of glycosylated and non- 
glycosylated mAb vs. pH; ■, glycosylated mAb; • , non-glycosylated mAb. Panel D: 
Paretto chart of ̂ -values. PEG molecular weights: 1450 or 8000Da; pHs: 4 or 6. Panel E: 
effect of temperature on ^-values. ■ , glycosylated mAb; • , non-glycosylated mAb
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A Paretto chart was constructed using three experimental factors: 1) type of mAb, 
2) PEG molecular weight and 3) pH. Figure 4D shows that the effect of those factors on fi 
is in the order: glycosylated or non-glycosylated> pH >PEG molecular weight. This 
order is opposite to the order observed for the onset of precipitation. The Paretto chart 
shows that the effect of the presence of carbohydrates chain on fi is more important than 
the effects of pH (associated with electrostatic repulsions). Therefore, although 
glycosylation has a moderate effect on the onset of precipitation it has a dominant effect 
on the precipitation efficiency by PEG.
The trends in the fi-values of all runs without GSL-II were analyzed in the context 
of the three models introduced earlier (Figure 5). The hydrodynamic radii of PEG used in 
the models were calculated using Eq.8 whereas the hydrodynamic radii of the proteins 
were measured using MALS. All three models show that the fi-values increase with an 
increase in the protein hydrodynamic radius and PEG molecular weight.
Figure 5. Comparison of fi-values of selected runs with three predictive models.Panels A 
(glycosylated mAb) and B (non-glycosylated mAb): fi-values vs. PEG MW. Panels C 
(PEG MW 1450 Da) and D (PEG MW 8000 Da): fi-values vs. protein radius. Inserts are
zoom outs of the plots
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The predicted ̂ -values of the glycosylated and non-glycosylated mAbs in Odijk’s 
and Sim’s models are similar to the experimental ones, but Atha and Ingham’s model 
overestimates those ̂ -values. The glycosylated mAb has a slightly larger molecular 
weight/hydrodynamic radius, which should yield higher ̂ -values. Both Odijk’s and 
Atha’s models are based on excluded volume considerations. Whereas Atha’s model 
assumes that protein and polymer are hard bodies (spheres and cylindrical fibers) Odijk’s 
model assumes that the polymer is a chain of monomers and that particles are of arbitrary 
shape but have an equivalent radius of gyration. By incorporating the hydrodynamic 
radius of PEG and the Stokes radius of the protein, Sim’s model provides a quick 
guideline to select precipitation conditions by PEG. Our experimental data show that pH 
has an effect on the ̂ -values that cannot be explained by any of the three models. 
Furthermore, all three models predict an opposite trend for the ̂ -values of glycosylated 
and non-glycosylated mAbs. Although the carbohydrate chain on the glycosylated mAb 
surface and its associated water shell increase the hydrodynamic radius, it does not 
promotes precipitation. On the contrary, the carbohydrate chain increases protein’s 
solubility. We argue that these models fail because they do not account for electrostatic 
repulsions/attraction and for hydration forces (enhanced by the presence of glycan 
groups). Enhanced hydration may justify the higher stability of the glycosylated mAb.
We also compared the ̂ -values with the predictions of the QSAR model. The 19 
molecular descriptors with highest variable influence on the projection (VIP) values are 
shown in Table 3 in descending order. As before, the direction of the influence of each 
factor on ̂ -values is given by the sign of the regression coefficient i.e., an increase in a 
molecular descriptor with a negative (-) regression coefficient makes the precipitation
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curve steeper and vice versa. Hammerling et al. [41] found that the three most effective 
factors affecting (  are solvent accessible surface area of protein (-) > protein molecular 
weight (-), number of atoms and chain length of the protein (-) > electrostatic surface 
potential (-).
Table 3. Descriptors with a VIP value >1.0 included in the final QSAR model for ( ­









totalSurf Solvent accessible surface area of protein in
A2 -
2 mass Molecular weight of the molecule -
3 nAtom number of atoms of the protein -
4 nAAcid Chain length of the protein -
5 shapeFactor Value for the sphericity of the protein -
6
sumNeg_PatchEsp Sum of negative ESP on the protein patch 
with the highest ESP value +
7 sumNeg_SurfEsp Sum of negative ESP on the protein surface +
8
median_PlaneESP Median value of ESP on the protein patch 
with the highest ESP value -
9
sumSurf_PatchEsp sum of ESP of surface points on the protein 
patch with the highest ESP value +
10
sum_SurfEsp Sum of ESP of surface point on the protein 
surface +
11
totalSurf_PatchEsp Solvent accessible surface area of the protein 
patch with the highest ESP value -
12
ninAbs_SurfHyd_4 Number of points with low hydrophobicity on 
the protein surface -
13
sumPos_SurfHyd Sum of points with positive hydropathy score 
on the protein surface
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Table 3. Descriptors with a VIP value >1.0 included in the final QSAR model for fi-
value and their description (cont.)
Sign
of




devA_PatchHyd (maximum hydrophobicity value-minimum 
hydrophobicity value)/mean value of 
hydrophobicity on the patch with the highest 
hydrophobicity
binAbs_SurfHyd_3 Number of points with low hydrophobicity on 
the protein surface
15 -
16 charge overall charge of protein +
median_ShellEsp Median value of ESP projected on a
shell around the molecule with a distance of 5
17 A -
18
max_PatchHyd Maximum value hydrophobicity on the 
protein patch with the highest hydrophobicity 
value +
19
sumNeg_SurfHyd Sum of negative hydrophobicity values on the 
protein surface +
aReproduced with permission from reference 33
These trends agree with Atha and Ingham’s[18] findings that larger proteins will 
have a steeper slope; i.e., the larger the molecular weight of the protein the higher the 
possibility of protein-protein interaction. This conclusion is contradicted by the findings 
of Sola et al. [43] who found that glycosylation enhances the stability of a-chymotrypsin 
because glycosylation increases the solvent accessible surface area linearly. In the QSAR 
model, the increased solvent accessible surface area is the result of an increasing number 
of hydrophilic amino acids in the polypeptide chain whereas in Sola et al.’s experiments
it is caused by glycosylation. Glycosylation will increase the solvent accessible surface 
area without affecting the size of the protein as much as hydrophilic amino acids. For 
example, arginine, the most hydrophilic amino acid residue, increases the solvent 
accessible surface area by ~1.2 A2/Da[44] but a typical glycan group like lactose will 
increase the area by ~1.5 A2/Da. The QSAR model cannot capture the carbohydrate 
chain’s effects on PEG-induced precipitation. This should not be surprising since the 
model does not include the same protein with and without glycan groups in the study and 
the glycan groups of the glycoproteins were not included in the MD simulation. The 
glycosylated mAb used in our experiments has a larger molecular weight and a larger 
solvent accessible surface area than the non-glycosylated mAb, but it has a flatter slope 
than the non-glycosylated counterpart, which contradicts the QSAR model. We argue that 
the solvent accessible surface area itself should not be used as one of the indicators of 
protein stability. Instead, solvent mediated forces, like hydration ones, would be a better 
predictor. The presence of glycan groups in a protein stabilizes the polypeptide chain by 
increasing its hydration. Protein stabilization caused by hydration forces is, in part, 
compensated by the destabilization caused by an increase in protein molecular size.
3.3. ADDITION OF LECTINS
Figure 2 shows that the addition of GSL-II produces a two-stage precipitation 
pattern at pH 4 and 6. The pattern consists of a first stage in which there is gentle 
decrease in the solubility followed by a second stage in which the solubility decreases 
sharply (Figure 2 dash line). Two mechanisms may be considered here: 1) GSL-II is not 
specific to non-glycosylated mAb, but it still lowers the m*-value sharply, which implies
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that the non-glycosylated mAb co-precipitated with GSL-II by adding PEG. The 
enhanced co-precipitation by PEG or hetero-interaction among variant proteins was 
reported by Miekka and Ingham. [45] They argue that it only occurs when the hetero­
complex is already present in the solution before PEG is added (proteins forming hetero­
complex before adding PEG). 2) GSL-II specifically binds to the mono-glycosylated 
mAb in the mixture, and that is the species that precipitates. Co-precipitation may also 
occur in the glycosylated mixture since 25% of mAb is non-glycosylated. Miekka and 
Ingham[45] also pointed out that the electrostatic interactions between proteins are the 
main reason of forming hetero-complex; i.e., the enhancement of co-precipitation in 
binary mixtures was a maximum at the pH intermediate between the two isoelectric 
points of the proteins (the proteins carried opposite net charge). Considering the 
isoelectric point of the mAb and the lectin, the hetero-complex should be more stable at 
pH 6 than at pH 4. In the next two paragraphs, the second precipitation stage is discussed 
in more detail.
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Figure 6. The m*-values and ̂ -values vs. pH for the precipitation curves with GSL-II and 
PEG 8000.Panels A (glycosylated mAb) and B (non-glycosylated mAb): comparison of 
the m*-values of precipitation curves with or without GSL-II. Panel C: comparison of 
the ^-values of glycosylated mAb and non-glycosylated mAb in the presence and absence
of GSL-II
The addition of GLS-II decreases the m*-value of both preparations (Figure 6A 
and B) and the effect is more pronounced at pH 6 where both the mAb and the lectin (pI: 
5.6~6) are positively charged. More importantly, pH 6 is in the middle the optimum 
binding pH range of GSL-II and GlcNAc is 4.2 ~8.8.[46] At the same pH (pH 4 and pH 
6), the m*-values of the glycosylated mAb are slightly smaller than the ones for the non- 
glycosylated mAb’s in the presence of GSL-II. Still, at pH 10.7, the glycosylated mixture 
cannot be precipitated even in the presence of GLS-II. pH 10.7 is outside GSL-II’s 
optimum binding pH range; and therefore its presence did not affect the anomalous 
behavior observed with the pure mAb at this pH.
The first stage absolute ̂ -values are smaller than the second stage ̂ -values (Table 
1). The second stage ̂ -values are around -0.087~ -0.12 for pH 4 and -0.20~ -0.24 for pH 
6 with and without GSL-II, respectively. The second stage P-values for both mAbs in the 
presence of GSL-II show a minimum at pH 6, which indicate that the PEG precipitation 
efficiency is highest at that pH. The enhancement of precipitation efficiency at pH 6 for 
both mAbs may be caused by the proximity of that pH to the isoelectric point of GSL-II 
(Ip 5.6~6.0). Because GSL-II also binds to GlcNAc, the differences in P-values of the 
glycosylated mAb with and without GSL-II are larger than for the non-glycosylated one. 
GSL-II lowers the PEG precipitation efficiency of the non-glycosylated mAb at all pHs 
but especially at pHs 4 and 10.7. Both the lectin and the mAb are either positively (pH 4) 
or negatively charged (pH 10.7) at those pHs and therefore electrostatic repulsions are 
strengthened. The same observation can be made for the glycosylated mAb at pH 4 and 
10.7. Once again, even in the presence of the lectin the glycosylated mAb does not 
precipitate in the range of PEG concentrations used in this study. GSL-II decreases the
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differences in the precipitation efficiency in between both preparations at all pHs. This is 
expected because the stability provided by the carbohydrate chains is lost as the lectin 
binds the mAb.
Figure 7. Chromatograms of the re-suspended precipitates in the presence of a 
lectin.Panel A: non-glycosylated mAb at 16.6 % precipitation. Panel B: glycosylated 
mAb at 29.6 % precipitation. Panel C: non-glycosylated mAb at 46.3 % precipitation. 
Panel D: glycosylated mAb at 65.3% precipitation
There are some differences in the precipitation pattern of the non-glycosylated 
protein and the glycosylated mixture and between the composition of the precipitate at 
the beginning of the precipitation and at the end (Figure 7) in the presence of GSL-II. At
the onset of precipitation (Figures 7 A and B) there are no major differences in the 
composition of the non-glycosylated and glycosylated mAb precipitates. However, in the 
middle of the precipitation curve (Figures 7 C and D) the precipitate of the non- 
glycosylated mAb is richer in the lectin (peak at ~ 9 ml) than the corresponding 
precipitate of the glycosylated one. Base on the HPLC-MALS results and recalling the 
co-precipitation mechanism, the first stage may represent the precipitation of hetero­
complex which is larger than glycosylated or non-glycosylated mAb, the second stage 
represents the free mAbs or the GSL-II-GlcNAc-mAb complex. For both systems C and 
D there is a portion of the precipitate that cannot be re-suspended. We speculate that this 
precipitate consists of aggregates of the lectin with the GlcNAc glycosylated mAb. The 
two-stage pattern disappeared in the non-glycosylated mAb precipitation curve at pH 
10.7, which implies the hetero-complex cannot be formed because both of the non- 
glycosylated mAb and GSL-II are negatively charged.
4. CONCLUSIONS
The results presented in this paper demonstrate the differences in the solubility of 
the glycosylated and non-glycosylated mAbs. PEG has lower precipitation efficiency and 
a larger onset concentration for the non-glycosylated than for the glycosylated mixture. 
This manuscript demonstrates that depletion and electrostatic forces are not sufficient to 
explain protein precipitation by PEG. The precipitation experiments with lectin show that 
there is a complex interplay between the mAbs and GSL-II. This is demonstrated by the 
analysis of the precipitates in the presence of a lectin. Our studies also show that
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available models to correlate or predict protein solubilities are unable to capture the effect
of glycosylation on protein solubility.
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II. SOLUBILITY OF LANOSTEROL IN ORGANIC SOLVENTS AND IN 
WATER-ALCOHOL MIXTURES AT 101.8 KPA
ABSTRACT
Lanosterol is a sterol derivative whose physicochemical properties are poorly 
understood. Pure lanosterol (>95%) was isolated from a crude product (54.6%) by a 
newly developed C18 reverse-phase high-performance liquid chromatography (HPLC) 
method. Purity and structure were confirmed by gas chromatography-mass spectrometry 
(GC-MS). The melting temperature and fusion enthalpy were determined to be 408.27 K 
and 23.61 kJ-mol-1, respectively. The solubility of lanosterol was measured in methanol, 
ethanol, acetonitrile, acetone, N,N-dimethylformamide (DMF), dimethyl sulfoxide 
(DMSO), ethyl acetate, isopropanol, w-propanol, water and binary system, water- 
methanol, water-isopropanol and water-ethanol using a static equilibrium set up from 
278.09 K to 338.78 K. The solubility of lanosterol increases with an increase in 
temperature. The mole fraction solubility of lanosterol in organic solvents has a minimum 
of 3.00*10-5 in methanol at 277.78 K and a maximum of 0.0048 in w-propanol at 318.93 
K. The solubility of lanosterol in organic solvents and in water-alcohol mixtures were 
correlated by the modified Apelblat equation and by the Wilson, NRTL, and UNIQUAC 
models. In addition, the binary water-alcohol systems were correlated with Apelblat- 
Jouyban-Acree model and van’t Hoff-Jouyban-Acree.
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1. INTRODUCTION
Lanosterol was first discovered in the non-saponifiable portion of lanolin. It is a 
tetracyclic triterpenoid that is synthesized in plants, animals and yeast.[1] It is also an 
intermediate in the biosynthesis of cholesterol.[2] Lanosterol inhibits the formation of 
paraneoplastic lesions in the colon of rat.[3] A side chain derivative of lanosterol (3P- 
hydroxy-5a-lanosta-8, 24-diene) acts as an inhibitor of A24 (25) sterol methyl 
transferase.[4] Lanosterol demethylase, 14-a-demethylase, is the primary target of 
antifungal drug.[5-7]In addition, besides its biochemical activity, lanosterol is the starting 
material of other steroids.[8]
The traditional isolation methods of lanosterol involve toxic or hazardous reagents 
like mercury (II) acetate and Li Al H4.[9] Even though an environment-friendly routine 
has been reported recently,[10] it also requires a relative long isolation process and 
experienced operators.
Recently, lanosterol has been found to dissolve protein aggregates in 
cataracts.[11] Unfortunately, the restoration of the affected lens only happened in animals 
(dogs and rabbits).[11] It has been argued that its ineffectiveness to reverse human 
cataracts is caused by the limited solubility of lanosterol in the delivery medium.[12] One 
means to increase the solubility of lanosterol is to use mixed-solvents. To the best of our 
knowledge, the solubility of lanosterol has not been previously reported in the open 
literature. We did find a product data sheet from Cayman Chemical Company.[13] They 
reported a solubility of lanosterol of 0.25 mg/ml and 3 mg/ml in ethanol and DMF 
respectively. The temperature was not specified.
In this report we present a new, fast and environmentally friendly purification 
process for lanosterol. This new method would make large amounts of highly pure sterol 
readily available. The solubility of the purified product was experimentally studied in 
acetone, acetonitrile, N,N-dimethylformamide (DMF), dimethyl sulfoxide (DMSO), ethyl 
acetate, ethanol, methanol, isopropanol, n-propanol and binary water-methanol, water- 




Crude lanosterol with a purity of 54.6% was purchased from Steraloids Inc. 
(Newport, IR). Crude lanosterol was purified with a Pre-RP-HPLC column and its purity 
was confirmed by gas-chromatography-mass-spectroscopy (GC-MS). Ultrafiltered type 1 
water (>18.0 MOhm/cm) was utilized as obtained from a Nanopure water system 
(Barnstead). Acetone, acetonitrile, DMF, DMSO, ethyl acetate, ethanol, isopropanol, n- 
propanol and methanol were ACS grade or better. All solvents were used “as received” 
without further purification. Details of solvents were summarized in Table 1.
Table 1. Sources and Mass Fraction Purity of Materials










lanosta-8,24-dien-3 - 79-63- Steraloid >95. prep-RF- GCb





8 none GC protic
45
Table 1. Sources and Mass Fraction Purity of Materials (cont.)










Ethanol (200 proof) 64-17­5 Aldrich
>99.


















Scientific 99.8 none GC aprotic
Acetonitrile 75-05­8
Fisher


















5 none GC aprotic
a Provided by the suppliers. 
b Gas chromatography.
c Gas chromatography with flame ionization detector. 
d Preparative reverse-phase high-performance liquid chromatography.
2.2. EXPERIMENTAL APPARATUS FOR SOLUBILITY DETERMINATION
The apparatus consists of a 25 mL three-neck glass flask with a water jacket to 
maintain the temperature. An Amporbe TMD-52 K-type thermocouple (Everett, WA) 
with a standard uncertainty of 0.01 K was used to monitor the solvent’s temperature in 
the glass flask. In order to keep atmospheric pressure and avoid solvent evaporation, a 
condenser was coupled to the glass flask. Magnetic stirrers were used in the water jacket 
and the flask to keep homogeneous temperature and lanosterol concentration. The
temperature in the water jacket was maintained by a Polyscience 9102 circulating bath 
(Niles, Illinois) with a temperature stability of 0.01 K. The schematic diagram of the 
experimental set up is shown in Figure S1.
2.3. ISOLATION OF LANOSTEROL
Crude lanosterol is a light yellow powder with a purity of 54.6% according to the 
manufacturer. The reverse phase chromatographic separation was done in an AKTA 
purifier system with an Agilent Eclipse XDB-C18 column (4.6mm*150mm). The mobile 
phase was methanol at a flow rate of 2 mL/min, the injection loop was 1mL, and the UV 
detector was set at 215nm. The lanosterol and dihydrolanosterol fractions were collected 
by a fraction collector. Fractions were pooled and vacuum-oven-dried before stored in a 
desiccator. Pure lanosterol and dihydrolanosterol are white powders.
The purity and identification of lanosterol and dihydrolanoterol were confirmed 
by an Agilent 7890B gas chromatography system with HP-5MS (Agilent Scientific,
USA) capillary column (30m length*0.25mm I.D.0.25mm film thickness) and an Agilent 
5977B mass selective detector (MSD). The carrier gas was helium (>99.999%) with a 
constant flow rate of 1 mL/min. The injection was in split-less-mode at 260 oC with a 20 
min solvent delay and an injection volume of 1pL. The column oven temperature 
program was set at 150 °C for the first 2 min, ramped to 230 °C (25 °C/min) further on to 
248 °C (1.0 °C/min) and finally to 325 °C (25 °C/min) with a 3.7 min hold. The transfer 
line temperature was set at 300 oC. The MSD analyzer was set at 70 eV and the electron 




The melting temperature and enthalpy of fusion of lanosterol were determined by 
a Q2000 Differential Scanning Calorimeter (DSC) (TA instruments). Lanosterol powder 
was vacuum-oven-dried before taking it to the DSC. About 2 mg of lanosterol was put in 
a closed DSC pan. An empty DSC pan was used as a blank. The samples were scanned 
from 338.15 K to 433.15 K with a heating rate of 5.0 K/min. DSC experiments were done 
in triplicate.
2.5. UV-VIS SPECTROSCOPY
Uv-vis spectra of lanosterol in methanol, the mobile phase in the HPLC 
experiments, were acquired by a HITACHI U2900 Uv-vis spectrometer. The spectra 
cover 190 nm to 1100nm and were acquired at room temperature.
2.6. SOLUBILITY DETERMINATION
Five or six mL of solvent and an excess amount of lanosterol were introduced 
into the 25 mL glass flask described previously. The desired temperature was set and the 
actual temperature in the glass vessel was recorded. Saturation was reached by adding 
lanosterol to the solvent until it did not dissolve anymore. Different mixing and settle 
down times were tested to determine a suitable equilibrium time. A combination of six 
hours mixing time and 6 hours settle down time was enough to reach equilibrium in all 
solvents. A sample of the upper clear portion of the mixture was withdrawn with a 
preheated or precooled glass pipette, transferred to a 1 mL microcentrifuge tube, diluted
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2.7. HPLC ANALYSIS
The concentration of lanosterol was determined by HPLC. A Shimadzu LC-20AB 
HPLC system with an Agilent ZORBAX SB-C18 column (2.1x50mm), CTO-10AS 
column oven, SIL-20AS autosampler and SPD-M20A diode array detector was used. 
Methanol was used as the mobile phase at a flow rate of 0.2 mL/min. The column oven 
temperature was 30 oC, the injection volume was 5 pL, and the UV detector wavelength 
was set at 215 nm.
100 times or to a proper concentration, and analyzed by HPLC. Each test was done in
triplicate.
The temperature dependence of the solubility was correlated by a modified 
Apelblat equation (Eq.1), which is derived from the van’t Hoff isochore by assuming that
3. DATA CORRELATION
the apparent partial molar enthalpy of the solute is a linear function of temperature.[14-
16]
ln x = A + B + C ln(T / K ) (1)T / K
where x is molar solubility of lanosterol in the solvent; and A, B and C are fitting
parameters.
The solubility of a solid at constant pressure can be described by,[17]
ln(— )
r,x, RTtJ { T




where Xi is the molar solubility of the solute, y is the activity coefficient of the solute i in 
the liquid phase, R is the gas constant, AfmHt,i is the molar enthalpy of fusion of the solute 
at the triple point temperature, Tt,t is the triple point temperature of the solute, and ACp,i is 
the differential molar heat capacity of the pure solute. Two assumptions are usually 
made[17-19] in Eq.2 that only introduce a slight error. The triple point and melting point 
temperatures are usually close to each other. Therefore, the triple point temperature Tt,t 
can be substituted by the melting temperature Tm,t. Moreover, the enthalpy of fusion at the 
triple point temperature AfusHtj can be substituted by the enthalpy of fusion at the melting 
point temperature AfUsHm,i. Second, the last two terms on the right-hand side of Eq.2 are 
of opposite signs and of similar magnitude; therefore, they cancel each other. Then Eq.2 
may be rewritten as,
ln(— )
r,x,
AfusH m,i /Tm,i i\
R T .  (T  ) (3)
3.1. WILSON MODEL
The Wilson’s equation[20] provides a good representation of excess Gibbs 
energies for a variety of miscible mixtures, particularly for solutions of polar components 
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where Aj are two adjustable parameters, is the energy of interaction between molecules
i and j, and Vi is the molar volume of the component i .
3.2. NRTL MODEL
The nonrandom two-liquid equation was first introduced by Renon.[21] Unlike 
the Wilson model, the NRTL model is applicable to partially miscible as well as 
completely miscible systems. The activity coefficients a binary mixture are given by,
ln y  = ==
l n  Y 2 =  =
* 2 1 ( '
G„
X + x2G2l- ) 2 +
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where Gj are adjustable parameters, Agj is the energy of interaction between molecules i 
and j  and a.12 is a nonrandom parameter which varies from 0.20 to 0.47.
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The UNIQUAC equation for excess Gibbs energy gE consist of two parts, a 
combinatorial part and a residual part.23 The activity coefficients for a binary mixture are 
given by,
3.3. UNIQUAC MODEL
ln 71 , O z d1 7}ln— + - qiln~ r +° 2(li li) 
X1 2 #1 7
-qln(@i +O2T21) + 02qC 21 12@1 ̂ @2̂21 @2 ^@1̂ 12
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where Tj are adjustable parameters, Auy are characteristic energies, the coordination 
number z is set to be 10. The area parameters, q, and volume parameters, r, for lanosterol
and the solvents were calculated according to references,[22-25] and summarized in 
Table 2.
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Lanosterol 426.05 15.4570 19.1675
Methanol 32.04 1.4320 1.4311
Ethanol 46.07 2.5880 2.5755
Isopropanol 60.10 3.1240 3.2491
n-Propanol 60.10 3.1280 3.2499
Acetone 58.08 2.2960 2.5735
Acetonitrile 41.05 1.7240 1.8701
DMF 73.09 2.7360 3.0856
DMSO 78.13 2.4720 2.8266
Ethyl Acetate 88.11 3.1160 3.4786
A linear temperature dependence of the adjustable parameters of the three models 
described above was assumed.[26] Therefore, Aj in the Wilson model, Tj in the NRTL 
model and the Tj in the UNIQUAC model are given by Eq. 20 to 22.
Vi
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where aj and bij are fitting parameters that are independent of composition and 
temperature.
3.4. APELBLAT-JOUYBAN-ACREE MODEL AND VAN’T HOFF-JOUYBAN- 
ACREE
The Apelblat -Jouyban-Acree model (Eq. 23) and van’t Hoff-Jouyban-Acree 
model (Eq. 24) [27] are classic thermodynamic models which used to correlate the binary
system.
B
ln x  = w  A  +-----~  + C  ln(T)
3 1 1 T / K  1
+ w, f  . B2 A  WW2 ^  w  v
A + T / k +C2ln(T)) + T t k  l  Jl ( W1 ~ w2 ̂
ln x3 = Wj , BA  +--------1 T / K
+ w. A2 +
B  ^ ww 2
T /K
1 2 i
+ O K  l J  ( w "  w2 >
(23)
(24)
where, xj is the mole fraction of lanosterol in binary mixture, wi and w2 are water mass 
fraction and alcohol mass fraction free of lanosterol. Ai, Bi Ci A2, B2, C2, Jo, Ji, and J2 are 
fitting parameters.
4. RESULTS AND DISCUSSION
Lanosterol purified by Pre-RP-HPLC has a purity of >95% by GC-MS. 
Additionally, dihydrolanosterol, which is the major impurity in commercial lanosterol, 
was obtained simultaneously. Lanosterol and dihydrolanosterol were identified using the
standard mass spectra of National Institute of Standards and Technology (NIST) MS 
spectral library and relevant references.[28] Ion groups at m/z of corresponding steroid 
were monitored, lanosterol (69,109,393,411,426) and dihydrolanosterol 
(43,69,395,413,428). The chromatogram and MS scan are shown in Figure S2 and S3.
The solubility of lanosterol in methanol, ethanol, isopropanol, w-propanol, 
acetonitrile, acetone, DMF, DMSO, and ethyl acetate as a function of temperature is 
summarized in Table 3 and is plotted in Figure 1. The solubility of lanosterol in 
water-methanol, water-ethanol, and water-isopropanol mixtures is summarized in Table 
4 and is plotted in Figures 2-4. The van’t Hoff plots of organic solvents and water- 
methanol, water-ethanol, and water-isopropanol mixtures are shown in Figures S4-S7.
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Figure 1. The mole fraction of lanosterol X2 in selected solvents at different 
temperatures. V, ethyl acetate; □ , acetone; ■, ethanol; • ,  DMF; A, DMSO; O, 
acetonitrile; ^ ,  methanol; +,isopropanol; x , w-propanol. The solid line are fittings of
data by the modified Apelblat equation
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Figure 2. The mole fraction of lanosterol (3) xj in water and water (l)-methanol (2) 
mixture at different temperatures. • ,  water V2=0 .0 0 ; X, V2=0.050; ^ ,  V2=0 .2 0 ; + ,  
V2=0.50; The insert shows the xj in □ , V2=0.70; O, V2=0.90 and ■  V2=1.00 ; —, the solid 
line are fittings of data by the modified Apelblat equation
Figure 3. The mole fraction of lanosterol (3) xj in water and water (1)-ethanol (2) mixture 
at different temperatures. □ , water V2=0.00; ■ , V2=0.050; • ,  V2=0.30; ^ ,  V2=0.60; the 
insert shows the X, v2=0.90; O, v2=1.00, —, the solid line are fittings of data by the
modified Apelblat equation
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Figure 4. The mole fraction of lanosterol (3) xj in water and water (l)-isopropanol (2) 
mixture at different temperatures.+ , water V2=0.00; □, V2=0.050; ■ , V2=0.30; the insert 
shows the O, V2=0.60; • ,  V2=0.90; X, v2=1.00; —, the solid line are fittings of data by
the modified Apelblat equation
Table 3. Mole fraction solubility X2 of lanosterol in organic solvents at temperature 
range (277.09K-337.99K) under 101.8 KPaa
T/K 1000x2 T/K 1 0 0 0 x2 T/K 1 0 0 0 x2
Methanol (A)b Ethanol (D)b Isopropanol (D)b
277.78 0.03 277.95 0.36 278.07 0.47
288.15 0.05 285.74 0.53 287.81 0.60
298.15 0.09 293.45 0.75 298.84 0.95
303.05 0.11 298.25 0.92 307.27 1.59




Table 3. Mole fraction solubility X2 of lanosterol in organic solvents at temperature
range (277.09K-337.99K) under 101.8 KPaa (cont.)
T/K 1000x2 T/K 1 0 0 0 x2 T/K 1 0 0 0 x2
Methanol (A)b Ethanol (D)b Isopropanol (D)b
316.95 0.21 312.35 1.68
321.65 0.32 318.05 2.14
w-propanol (D)b Acetone (A)b Acetonitrile (A)b
278.07 0.90 278.65 0.66 277.09 0.03
287.81 1.44 283.75 0.87 288.55 0.06
298.84 2.09 288.45 1.05 293.35 0.09
307.27 3.04 293.25 1.27 298.15 0.13
318.93 4.78 298.05 1.57 303.05 0.15
302.75 1.93 307.55 0.19
307.55 2.37 312.25 0.26
318.36 3.60 317.05 0.38
DMF (amorphous)b DMSO (amorphous)b Ethyl Acetate (A)b
277.15 0.35 293.95 0.15 277.67 0.76
284.65 0.51 297.65 0.19 288.55 1.27
289.15 0.63 302.35 0.24 293.25 1.65
294.65 0.73 307.15 0.31 298.05 1.87
297.35 0.89 312.95 0.42 302.85 2.35
300.15 1.03 318.69 0.57 307.45 2.84
303.05 1.38 337.99 1.36 318.64 4.43
308.46 1.87
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Table 3. Mole fraction solubility X2 of lanosterol in organic solvents at temperature
range (277.09K-337.99K) under 101.8 KPaa (cont.)
T/K 1 0 0 0 x2 T/K 1000x2 T/K 1000x2
DMF (amorphous)b DMSO (amorphous)b Ethyl Acetate (A)b
318.55 2.94
ax2 is the experimental mole fraction solubility of lanosterol at temperature T; the 
standard uncertainties u are u(T) = 0.01 K, u(P) = 0.22 kPa; the relative standard 
uncertainty ur is ur(x2) = 0.023.
bLanosterol crystal forms in equilibrium with solvents.
Table 4. Mole fraction solubility xj of lanosterol (3) in water, water(1)-methanol(2), 
water(1)-ethanol(2) and water(1)-isopropanol (2) binary mixtures at the temperature 
range (278.15 K-338.78 K) under 101.8KPaa
T/K W x s













7 0.0032 0.0035 0.0037 0.0038 0.0648 13.0
306.8
1 0.0053 0.0059 0.0063 0.0079 0.116 29
316.9
4 0.0093 0.0133 0.0151 0.0206 0.223 54
328.9
7 0.0175 0.030 0.0370 0.047 0.47 111
338.7
8 0.028 0.067 0.073 0.101 1.15











5 0.00141 0.0168 0.061 0.174 223
T/K 10x3
water (1)- ethanol(2) (A)b
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Table 4. Mole fraction solubility xj of lanosterol (3) in water, water(1)-methanol(2),
water(1)-ethanol(2) and water(1)-isopropanol (2) binary mixtures at the temperature











5 0.00193 0.028 0.090 0.29 334
298.1
5 0.0042 0.046 0.141 0.44 468
308.1
5 0.0062 0.076 0.178 0.84 691
318.1
5 0.0123 0.114 0.221 1.20 769











5 0.00141 0.0088 0.080 10.70 162
288.1
5 0.00193 0.0122 0.090 14.2 300
298.1
5 0.0042 0.0139 0.113 20.8 412
308.1
5 0.0062 0.0171 0.123 25 522
318.1
5 0.0123 0.0223 0.130 31 708
ax3 is the experimental mole fraction solubility of lanosterol at temperature T, V2 is volume 
fraction of alcohols in water-alcohols binary system free of lanosterol, W2 is mass fraction 
of alcohols in water-alcohols binary system free of lanosterol; the standard uncertainties u 
are u(T) = 0.01 K, u(P) = 0.22 kPa; the relative standard uncertainty ur is ur(x3) = 0.043.
bLanosterol crystal forms in equilibrium with solvents.
As shown in Figure 1, the solubility of lanosterol increases with increasing 
temperature in all the solvents studied. From 277.78 K to 338.15 K, the solubility of 
lanosterol is the largest in w-propanol and the lowest in methanol. The solubility of 
lanosterol in DMF is lower than in ethanol below 300.15 K but it is higher above 300.15 
K. Furthermore, below 298.15 K the lanosterol solubility in isopropanol is lower than in 
the ethanol, above 298.15 K the order between isopropanol and ethanol switched. Around 
277.15 K the lanosterol solubility increases according to the following order: methanol< 
acetonitrile< DMF< isopropanol< acetone< ethanol< ethyl acetate< w-propanol and 
around 318.15 K, the order change to: methanol< acetonitrile< DMSO< ethanol< 
isopropanol< DMF< acetone< ethyl acetate< w-propanol.
The solvents were sorted into two groups according to their H-bond capacity. The 
protic solvents group includes methanol, ethanol, w-propanol and isopropanol, and the 
aprotic solvents group includes DMSO, DMF, acetone, acetonitrile and ethyl acetate. In 
each group, the solubility of lanosterol increases with decreasing solvent polarity except 
isopropanol. In addition, the solubility of lanosterol increases with decreasing Hanson 
solubility parameters within each group except isopropanol in the protic solvents group, 
except acetonitrile in aprotic solvents group. The Hanson solubility parameters, 
polarity[29, 30] and polarizability[31] of solvents are summarized in Table S1.
Lanosterol has a highly hydrophobic steroid domain with a hydroxyl motif, which 
makes the molecule weakly polar. The predominant intermolecular forces in the protic 
solvents group are H-bond and dipole-dipole interactions. Polar protic solvents cannot 
dissolve lanosterol efficiently because the weak H-bond between lanosterol and ethanol 
or methanol cannot replace the strong H-bond in pure solvents without an energy penalty.
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Lanosterol is less soluble in methanol than in ethanol, isopropanol and w-propanol, which 
is expected because methanol is a better H-bond molecule than other alcohols studied in 
this work. The solubility of lanosterol increase while increasing alkyl chain length of 
alcohols except isopropanol, maybe due to the hydroxyl group is in the middle of the 
isopropanol alkyl chain. The solvents in the aprotic solvents group are only H-bond 
acceptors. In such systems, the H-bond interactions are weaker than in the protic solvents 
group. The dipole-dipole interaction in pure solvents become weaker as the polarity 
decreases, then the weak dipole-dipole interaction between lanosterol and solvents may 
easily replace the dipole-dipole interaction in pure solvents, causing higher solubility. 
Dispersion forces or induced-dipole interactions may also contribute to dissolution. 
Dispersion forces depend on the polarizability of solvents. In the aprotic solvents group, 
the polarizabilities of each solvent are in the order of ethyl
acetate>DMSO>DMF>acetone>acetonitrile, but the solubilities of lanosterol do not 
follow the order of polarizabilities except for ethyl acetate and acetonitrile. The above 
observations lead to the conclusion that the lower the polarity of solvent the higher the 
solubility of lanosterol, and that dispersion forces may also affect the solubility to some 
degree in some solvents. To increase the solubility of lanosterol, n-hexane (polarity 0.9) 
was tested. However, the solubility of lanosterol in w-hexane (data not shown) is even 
lower than in ethyl acetate (polarity 23.0). Therefore, the dissolution of lanosterol is not 
only affected by the polarity of solvent but by a synergy of dipole-dipole interactions, H- 
bond interactions and dispersion forces. This suggests that a low polarity solvent and a 
weak H-bond capacity solvent mixtures may enhance the solubility of lanosterol. For
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The addition of alcohols to water increased lanosterol’s solubility. That indicates 
that the alcohols are cosolvents of lanosterol in water. Lanosterol solubility increased 
with increasing of temperature in water-alcohol mixtures and increased with increasing 
alcohol content.
The PXRD pattern (Figure S8) of lanosterol before the solubility experiments 
were conducted is identical to a previously reported pattern[33]. Ref 33 reported PXRD 
for lanosterol powder and lanosterol crystallized in diisooctylphthalate (DIOP). In the 
patent owned by Pan et al. [34] showed PXRD pattern of different lanosterol crystal 
forms. According to this patent the crystal form of powder lanosterol is anhydrous Form 
A. Figure S8 shows that the PXRD patterns changed after solubility experiments in 
ethanol, isopropanol and w-propanol, which indicate that there is another polymorph 
(Form D, according to the same patent) formed during the experiments. Furthermore, the 
PXRD experiments show that the solid at equilibrium with solutions of lanosterol in 
DMSO and DMF has lost the crystalline structure and forms amorphous precipitates. The 
PXRD also shows that after vacuum-oven drying, the amorphous precipitate obtained 
from precipitation in DMF and DMSO forms crystalline structures. In the other pure 
solvents and in water-alcohol mixtures, the PXRD patterns are identical to the one 
obtained with powder lanosterol. The crystal forms of lanosterol in equilibrium with 
solvents were submitted in Table 3 and Table 4.
The melting temperature and enthalpy of fusion of the purified lanosterol were 
determined to be 408.27 K with an uncertainty u(Tm) = 0.5 K and 23.61 kJ-mol-1 with an
example, it has been found that mixtures of ethanol and hexane increase the solubility of
cholesterol.[32]
uncertainty u(AHfus) = 0.14 kJ-mol"1, respectively. The molar extinction coefficient in 
methanol at 202 nm was 382,801(M-cm)-1. Literature values of melting temperatures are 
reported as the width of the endothermic peak, the onset of the endothermic peak or its 
mean value. The melting temperature reported in this work is the onset temperature of 
the endothermic peak because this value is less sensitive to heating rates and sample 
mass. It is lower than the values reported by Boar et al.[8] (413.15 K), Maienthal and 
Franklin[35] (411.15 K-413.15 K), Johnston and Bloch[9] (410.15 K-411.15 K) and 
Jagodzinski and Rodewald[10] (419.15 K-420.15 K). The differences may be caused by 
differences in purity, by the presence of different impurities because of the different 
separation methods used and/or by the use of different experimental protocols. For 
example, it has been found that the heating rate,[36] which is not reported in some of the 
data, affects melting temperature measurements. [36] The DSC thermograph is shown in 
Figure S9.
Figure S10 shows the DSC data for lanosterol solids obtained in solvents whose 
PXRD patterns are different from the starting material’s one. The DSC results for 
ethanol, isopropanol and w-propanol show two endothermic peaks. The peak around 370 
K may be caused by eutectic process. The melting temperature and enthalpy of fusion of 
lanosterol crystal formed in ethanol, isopropanol and w-propanol are 390.52 K with an 
uncertainty u(Tm) = 0.5 K and 6.97 kJ-mol-1 with an uncertainty u(AHfUs) = 0.21kJ-mol-1, 
respectively. The DSC results of the dried precipitates from DMSO and DMF both show 
an endothermic peak around 386 K (Figure S10) which agree with PXRD patterns.
The solubility of lanosterol in organic solvents was correlated by the modified 
Apelblat equation (Table 5), the Wilson, NRTL and UNIQUAC models (Table 6 except
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DMSO and DMF). The root mean square deviation (RMSD) of the experimental








where N  is the number of experimental data in each solvent at a given temperature.
In addition, in order to evaluate each model, the average absolute deviation 
percentages (AADP) and relative average deviation (RAD) were calculated.
RAD = ■
N ‘
1 v x;xp —x
N IN x ;xp





The molar volume of lanosterol and the solvents were taken from Advanced 
Chemistry Development ACD/Chemsketch Software (© 1994- 2018 ACD/Laboratories) 
whereas the melting temperature (Tm,i) and enthalpy of fusion (AfUsHm,i) of lanosterol were 
measured in this work.
Table 5 and Table 6 show that the correlated solubilities by all four models are in
1
good agreement with experimental data. The largest RMSD is 9.45*10-05 for the Wilson 
model in w-propanol. The largest AADP is 8.26% for the NRTL model in isopropanol. 
Assuming that ACp,t ~ 0 may have contributed to the deviation.[32]
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Table 5. Parameters of the Apelblat Equation and Root Mean Square Deviation 
(RMSD) and the average absolute deviation percentage (AADP) for Lanosterol in
Selected Solvents
Solvents A B/T C
AADP
105 RMSD %
Methanol -823.88 32557.15 123.77 0.92 9.05
Ethanol -25.90 -2464.60 4.77 2.39 1.22
w-Propanol -139.54 2899.70 21.70 4.33 2.72
Isopropanol 16.99 -4281.88 -1.67 7.66 8.07
Acetone -40.66 -1686.88 6.99 1.60 1.13
Acetonitrile -604.28 22145.50 91.42 0.80 7.42
DMF 88.49 -8649.48 -11.65 7.11 7.58
DMSO 39.58 -6431.80 -4.66 0.20 0.65
Ethyl Acetate -44.93 -1478.80 7.66 3.85 1.65
The solubility of lanosterol in binary water-alcohol mixtures was correlated by the 
Apelblat-Jouyban-Acree and the van’t Hoff-Jouyban-Acree models. The RMSD, RAD 
and fitted lanosterol mole fraction X3cal are shown in Table S2 and Figure S11-S13. The 
van’t Hoff-Jouyban-Acree model fits the data better than the Apelblat-Jouyban-Acree 
model. Most of the deviations are at the very low solubilities observed at very low 
organic solvent mole fractions.
The parameters bij/T in the Wilson model are negligible when compared to aij
(Table 6) which are approximately equal to the
A X ,
RT
terms in Eq. 6 and 7. The AXj in
Wilson model of the lanosterol-methanol system are AX12 =-2932.32 and AX21 =13749.52
which are of the same order of magnitude of a similar steroid molecule, desmosterol in
methanol (AA12 =-3827.52 and AA21 =14298.65).
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Table 6. Interaction Parameters and Root Mean Square Deviation (RMSD) and the 




ai2 bn/K a2i b2i/K 105 RMSD AADP%
Methanol 2.88 -6.74 -10.37 5.73 0.63 4.61
Ethanol 1.31 0.091 -9.30 4.44 5.15 2.84
Isopropanol 0.97 -0.24 -8.77 4.13 3.97 1.84
w-Propanol 1.00 0.46 -8.09 3.41 9.45 3.04
Acetone 2.07 -2.57 -6.29 3.85 4.97 2.07
Acetonitrile 2.76 -11.40 -10.15 5.15 1.28 6.32
Ethyl
Acetate 1.82 -0.93 -5.85 -0.28 7.83 2.81
Solvent
NRTLa
ai2 bi2/K a2i b2i/K 105 RMSD AADP%
Methanol -4.62 -44.01 3.28 396.66 1.97 5.37
Ethanol -2.11 -1128.88 2.01 813.17 2.70 1.91
Isopropanol -4.42 130.31 2.39 575.61 8.62 8.26
n-Propanol -10.31 2476.33 3.57 23.18 5.74 2.03
Acetone -3.00 43.04 2.62 235.76 1.65 1.05
Acetonitrile -1.78 2456.85 -336.24 -364.61 1.36 4.55
Ethyl
Acetate -1.52 -89.38 1.26 295.20 3.77 1.40
UNIQUAC
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Table 6. Interaction Parameters and Root Mean Square Deviation (RMSD) and the
Average Absolute Deviation Percentage (AADP) for Wilson, NRTL and UNIQUAC
Models (cont.)
Solvent
a i2 b i2 / K a 2 i b 2 i / K 105 R M S D A A D P %
Methanol -1.76 -125.06 0.71 25.41 0.52 3.46
Ethanol 0.83 -200.20 -1.41 40.28 1.81 1.27
Isopropanol -1.18 -130.38 0.42 29.89 7.56 3.98
n-Propanol 0.19 -150.04 -0.86 10.89 3.79 1.87
Acetone 0.23 -49.08 -0.90 6.49 1.45 1.01
Acetonitrile -1.49 -63.40 0.74 -33.07 0.66 3.56
Ethyl
Acetate 0.44 -52.48 -1.05 -5.14 3.76 1.38
a The nonrandom parameter in the NRTL model is a  =  0.2
Furthermore, a2 i  increases with decreasing solvent polarity within each solvent 
groups. This indicates that with decreasing solvent polarity, the interaction energy 
difference between the solvent and lanosterol and between the pure solvents (AXij) 
becomes smaller. Then it leads to activity coefficients approximately equal to one. If the 
activity coefficients are closer to one, the interactions between solute and solvent are 
similar to solvent-solvent interactions. Therefore, replacement of solvent-solvent bonds 
by solvent-solute bonds is favorable and the solubility increases. This dependence of the 
coefficients of Wison model with solvent polarity was not found in the other two models.
The interaction parameters, Agi 2 =gi 2-gi i ,  Ag2 i =g2 i -g22 and Aui 2= ui 2 -ui i ,  
Au2 i= u2 i - u22 for the NRTL and UNIQUAC models are presented in Table S3. The gu and
uu are the energy of evaporation of lanosterol in each solvent. The %■ and gj are the 
interaction energies between lanosterol and solvents such as gi2=g2i, ui2=u2i. In the 
NRTL model, the Agn are positive for all solvents, which indicates that the interaction 
energy between solvent and solute are larger than the evaporation energy of the solvents. 
Ag2i are negative in all solvents. Aui2 in the UNIQUAC model are all positive whereas 
the Au2i are negative for all solvents. Although the Auj and Agj in both models are related 
to the evaporation energy of solute and solvents, the values show a large difference. The 
discrepancy between the two models is likely to be caused by the absence of an entropic 
term in the NRTL model.[37, 38]
The mixing properties, AmixG, AmixS and AmixH were computed using the Wilson 
Equation and summarized in Table S4. The mixing enthalpies (AmixH) in all solvents are 
positive except for acetonitrile and ethyl acetate, therefore, the dissolution of lanosterol is 
an endothermic process. Only for acetonitrile and ethyl acetate, the dissolution is 
exothermic. The mixing entropies (AmixS) are positive for all solvents, which indicates all 
solvent-lanosterol systems become more disorder and the dissolution is an entropy-driven 
process. The mixing Gibbs energy (AmixG) of all solvents are negative and decrease with 
increasing temperature. The dissolution of lanosterol in all selected solvents is 
spontaneous.
In the absence of binary interaction parameters, the solubility of lanosterol in 
methanol-water systems at 298.15 K were predicted by the modified Wilson model
1 sat 1 W (1 + ln xSat) w  (1 + ln xSat) . .-  ln xSat = 1----^ ^ ----^ ^  (28)
W1 + W2^2 V 21 + W2
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where x ^ 1 is the solubility of the solute in the mixed solvents xSat and x ŝ a are the solute
solubility in organic solvent and water at a given temperature; Wi and W2 are the mass 
fractions of organic solvent and water; and are the energy of interaction parameters. 
Replacing the with Abraham solute parameters in Eq. 28 we obtain,
-  ln x?at = 1 — W (1 + ln xSat)
W\ + W  (J  + J E  + J 2S + J yA + J + J V )
W2 (1 + ln xS )
W (J  '0+ J  \ E + J  \  S + J  \  A + J  \  B + J  \  V) + w2
(29)
where Ji and Ji terms are model constants; E, S, A, B, V are Abraham solute parameters, 
which are the excess molar refraction (E), the dipolarity/polarizability of the solute (S), 
the solute's hydrogen-bond acidity and basicity(A, B) and the McGowan volume of the 
solute(V). Barzegar-Jalali et al. [39] suggested a set of J  and J ’ that were regressed from 
41 drug solubility data sets for methanol-water systems. The trained version of the 
modified Wilson model for methanol-water systems is,
W (1 + ln xfat)-  ln x.Sat = 1 —
W + w2 (0.626 -  0.622E + 0.339S + 0.246A + 0.218B -  0.096V)
____________________w2(1 + ln x2Sat)___________________
W (1.525 + 0.108E -  0.109S + 0.092A + 0.586B -  0.228V) + w2
(30)
The Abraham solute parameters of lanosterol were calculated by ACD/I-Lab 
software: E  = 1.41, S = 1.67, A = 0.31, B = 0.9, V =3.8739.
The solubility of lanosterol in methanol-water mixtures was measured and 
compared with the solubility predicted by Eq. 30 (Figure 5). The molar solubility of 
lanosterol in water is 3.2 x10-9. Interestingly, the modified Wilson model predicted that 
the lanosterol’s solubility first decreases and then increases with increasing methanol
volume fraction.
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Figure 5. The solubility of lanosterol (X3) in water (l)-methanol (2) binary mixtures 
compare with the solubility predicted by modified Wilson model.■, 296.67 K; • ,  306.81 
K; A, 316.94 K; V, 328.97 K; □ , 338.78 K. The solid line represents solubility 
prediction by the modified Wilson model. The inset shows natural logarithmic solubility
The solubilities predicted by Eq. 30 deviate less from the experimental data at low 
and high methanol volume fraction. The overall relative deviation is 344 %. The modified 
Wilson model may only applicable at high methanol content for lanosterol.
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The solubility of lanosterol in nine organic solvents from 277.09 K to 338.15 K 
and in water-alcohol mixtures from 277.78 K to 338.78 K was measured. The melting 
temperature and enthalpy of fusion of lanosterol were determined to be 408.27 K and 
23.61 kJ-mol-1, respectively. The solubility of lanosterol in n-propanol is the largest one 
among the selected solvents. The activity coefficient models of Wilson, NRTL and 
UNIQUAC correlated the experimental data satisfactorily. The Apelblat -Jouyban-Acree 
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APPENDIX
SUPPORTING INFORMATION OF II. SOLUBILITY OF LANOSTEROL IN 
ORGANIC SOLVENTS AND IN WATER-ALCOHOL MIXTURES AT 101.8 KPA
Table S1. The solubility parameter, polarity and polarizability of solvents 
Solubility
Solvent Parameter^ Polarizability
(J-cm"3)0'5 Polaritya (Water 100) (A3)
Methanol 29.52 76.2 3.26
Ethanol 26.58 65.4 5 13
Isopropanol 23.8 54.6 7 14
w-propanol 24.5 61.7 7 23
Acetone 20.05 35.5 6 47
Acetonitrile 24.09 46 4 44
DMF 23.97 40.4 7 93
DMSO 26.33 44.4 8 03
Ethyl Acetate 18.35 23 8 87
n-Hexane 14.9 0.9 11.94
a Taken from Reference 1 and 2. 




Table S2. Parameters for the Apelblat-Jouyban-Acree and van’t Hoff-Jouyban-Acree
models, Root Mean Square Deviation(RMSD) and the relative average deviation (RAD)
for the solubility of lanosterol (xj) in water-methanol binary mixturesa
Apelblat- Hoff-
Jouyban- Jouyban
T/K W2 X3exp v cal-apb X3 v cal-van X3 Acree -Acree
296.67 0.00 3.25E-09 2.27E-09 5.44E-10 Ai -497.83 Ai 10.81
306.81 0.00 5.30E-09 2.51E-09 1.57E-09 Bi 20730.00 Bi -9537.74
316.94 0.00 9.33E-09 2.97E-09 4.25E-09 Ci 71.67 A2 9.36
328.97 0.00 1.75E-08 3.92E-09 1.28E-08 A2 -823.63 B2 -5620.29
338.78 0.00 2.81E-08 5.19E-09 2.96E-08 B2 32600.00 Jo -5277.64
296.67 0.040 3.53E-09 3.55E-09 1.14E-09 C2 123.70 Ji 126.75
306.81 0.040 5.95E-09 3.99E-09 3.22E-09 Jo -4922.56 J2 8573.20
316.94 0.040 1.33E-08 4.80E-09 8.47E-09 Ji -685.88
328.97 0.040 3.02E-08 6.48E-09 2.48E-08 J2 6864.09
338.78 0.040 6.56E-08 8.74E-09 5.62E-08
296.67 0.16 3.66E-09 4.37E-09 2.04E-09
306.81 0.16 6.34E-09 5.34E-09 5.62E-09
316.94 0.16 1.51E-08 7.01E-09 1.45E-08
328.97 0.16 3.70E-08 1.05E-08 4.12E-08
338.78 0.16 7.33E-08 1.54E-08 9.16E-08
296.67 0.44 3.83E-09 3.69E-09 1.34E-09
306.81 0.44 7.91E-09 5.62E-09 3.68E-09
316.94 0.44 2.06E-08 9.21E-09 9.48E-09
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water(1 )-methanol (2)
Table S2. Parameters for the Apelblat-Jouyban-Acree and van’t Hoff-Jouyban-Acree
models, Root Mean Square Deviation(RMSD) and the relative average deviation (RAD)
for the solubility of lanosterol (xj) in water-methanol binary mixtures (cont.)








328.97 0.44 4.72E-08 1.80E-08 2.70E-08
338.78 0.44 1.01E-07 3.27E-08 6.01E-08
296.67 0.65 6.49E-08 8.24E-08 3.46E-08
306.81 0.65 1.01E-07 1.33E-07 8.45E-08
316.94 0.65 1.98E-07 2.33E-07 1.95E-07
328.97 0.65 4.74E-07 4.97E-07 4.92E-07
338.78 0.65 1.00E-06 9.79E-07 9.98E-07
296.67 0.88 1.30E-05 1.77E-05 1.45E-05
306.81 0.88 2.94E-05 2.86E-05 2.87E-05
316.94 0.88 5.47E-05 5.08E-05 5.43E-05
328.97 0.88 0.00011 0.000111 0.00011
277.78 1.00 2.70E-05 3.69E-05 1.9E-05
288.15 1.00 4.86E-05 5.03E-05 3.93E-05
298.15 1.00 8.83E-05 7.7E-05 7.56E-05
303.05 1.00 0.00011 9.87E-05 0.000103
307.55 1.00 0.00013 0.00013 0.00013
312.15 1.00 0.00016 0.00017 0.00018
316.95 1.00 0.00021 0.00023 0.00023
321.65 1.00 0.00032 0.00031 0.00030
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Table S2. Parameters for the Apelblat-Jouyban-Acree and van’t Hoff-Jouyban-Acree
models, Root Mean Square Deviation(RMSD) and the relative average deviation (RAD)




X3exP xj cal-apb v cal-van x3
Jouyban- Jouyban









a W2 is mass fraction of alcohols in a water-alcohol binary system free of lanosterol; x / al" 
apb and x / al"van are calculated lanosterol mole fractions by the Apelblat-Jouyban-Acree and 
van’t Hoff-Jouyban-Acree models respectively.
Table S3. Parameters for the Apelblat-Jouyban-Acree and van’t Hoff-Jouyban-Acree 
models, Root Mean Square Deviation(RMSD) and the relative average deviation (RAD) 
for the solubility of lanosterol (xj) in water-ethanol binary mixtures.a
water(1 )-ethanol(2)
T /K W 2 x 3 exP cal-apbx 3
278.15 0.00 1.43E-09 4.37E-09
288.15 0.00 1.94E-09 6.33E-09
298.15 0.00 4.17E-09 9.68E-09






9E-09 Ai -507.613 Ai -9.35289
1.22E-08 Bi 19136.32 Bi -2721.48
2.54205
1.62E-08 Ci 74.45794 A2 2
2.22E-08 A2 -727.768 B2 -2785.93
80
water(1 )-ethanol(2)
Table S3. Parameters for the Apelblat-Jouyban-Acree and van’t Hoff-Jouyban-Acree
models, Root Mean Square Deviation(RMSD) and the relative average deviation (RAD)
for the solubility of lanosterol (xj) in water-ethanol binary mixtures (cont.)








318.15 0.00 1.25E-08 2.82E-08 2.81E-08 B 2 30018.84 J o -1969.19
278.15 0.040 1.73E-08 1.28E-08 1.19E-08 C 2 108.8534 J l -14.3242
288.15 0.040 2.79E-08 1.56E-08 1.65E-08 J o -2745.25 J 2 5998.03
298.15 0.040 4.57E-08 2.05E-08 2.24E-08 J l 1714.521
308.15 0.040 7.64E-08 2.88E-08 2.97E-08 J 2 10612.25
318.15 0.040 1.06E-07 4.27E-08 3.88E-08
278.15 0.25 6.07E-08 1.01E-07 6.54E-08
288.15 0.25 8.96E-08 1.22E-07 9.31E-08
298.15 0.25 1.35E-07 1.61E-07 1.29E-07
308.15 0.25 1.80E-07 2.27E-07 1.76E-07
318.15 0.25 2.25E-07 3.42E-07 2.35E-07
278.15 0.54 1.73E-07 1.93E-07 4.74E-07
288.15 0.54 2.87E-07 2.48E-07 7.10E-07
298.15 0.54 4.42E-07 3.50E-07 1.03E-06
308.15 0.54 8.38E-07 5.34E-07 1.47E-06
318.15 0.54 1.20E-06 8.72E-07 2.05E-06
278.15 0.88 0.00022 0.00034 0.00025
288.15 0.88 0.00033 0.00038 0.00034
298.15 0.88 0.00047 0.00046 0.00047
308.15 0.88 0.00069 0.00063 0.00062
318.15 0.88 0.00077 0.00093 0.00081
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Table S3. Parameters for the Apelblat-Jouyban-Acree and van’t Hoff-Jouyban-Acree
models, Root Mean Square Deviation(RMSD) and the relative average deviation (RAD)
for the solubility of lanosterol (xj) in water-ethanol binary mixtures (cont.)
water(1 )-ethanol(2)
van’t











318.05 1.00 0.0021 0.0021 0.0020
312.35 1.00 0.0017 0.0017 0.0017
307.15 1.00 0.0014 0.0014 0.0015
302.85 1.00 0.0012 0.0012 0.0013
298.25 1.00 0.0010 0.0010 0.0011
293.45 1.00 0.00092 0.00091 0.0010
285.74 1.00 0.00082 0.00080 0.00074
277.95 1.00 0.00073 0.00075 0.00056












a W2 is mass fraction of alcohols in a water-alcohol binary system free of lanosterol; x / al" 
apb and x / al"van are calculated lanosterol mole fractions by the Apelblat-Jouyban-Acree and 
van’t Hoff-Jouyban-Acree models respectively.
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water(1)-isopropanol (2)
Table S4. Parameters for the Apelblat-Jouyban-Acree and van’t Hoff-Jouyban-Acree
models, Root Mean Square Deviation(RMSD) and the relative average deviation (RAD)
for the solubility of lanosterol (xj) in water-isopropanol binary mixtures
T/ K W2 X3exp v cal-apb X3
278.15 0.00 1.43E-09 4.37E-09
288.15 0.00 1.94E-09 6.33E-09
298.15 0.00 4.17E-09 9.68E-09
308.15 0.00 6.21E-09 1.70E-08
318.15 0.00 1.25E-08 2.82E-08
278.15 0.040 8.79E-09 3.68E-09
288.15 0.040 1.23E-08 4.75E-09
298.15 0.040 1.41E-08 6.56E-09
308.15 0.040 1.69E-08 9.59E-09
318.15 0.040 2.21E-08 1.47E-08
278.15 0.25 7.97E-08 7.64E-08
288.15 0.25 9.02E-08 1.02E-07
298.15 0.25 1.07E-07 1.42E-07
308.15 0.25 1.19E-07 2.06E-07
318.15 0.25 1.31E-07 3.10E-07
278.15 0.54 1.07E-05 8.03E-06









8.43E-13 A i -507.61 A i
5.75931
4
8.75E-13 B i 19136.32 B i -3771.12
9.06E-13 C i 74.45 A 2 -26.6873
9.41E-13 A 2 16.99 B2 -330.517
9.69E-13 B 2 -4281.89 Jo
7328.28
1
1.55E-11 C 2 -1.67 J i -6306.84
1.53E-11 Jo 1632.95 J2
3343.80
4
1.5E-11 J i -1464.48










Table S4. Parameters for the Apelblat-Jouyban-Acree and van’t Hoff-Jouyban-Acree
models, Root Mean Square Deviation(RMSD) and the relative average deviation (RAD)
for the solubility of lanosterol (xj) in water-isopropanol binary mixtures (cont.)
water(1)-isopropanol(2)
van’t











298.15 0.54 2.08E-05 1.53E-05 2.05E-05
308.15 0.54 2.51E-05 2.17E-05 2.17E-05
318.15 0.54 3.10E-05 3.10E-05 2.28E-05
278.15 0.88 0.00016 0.00019 0.00020
288.15 0.88 0.00030 0.00029 0.00028
298.15 0.88 0.00041 0.00044 0.00039
308.15 0.88 0.00052 0.00064 0.00053
318.15 0.88 0.00071 0.00093 0.00071
278.07 1.00 0.00047 0.00041 0.00041
287.81 1.00 0.00060 0.00065 0.0006
298.84 1.00 0.00095 0.00105 0.0010
307.27 1.00 0.0016 0.0015 0.0015
318.93 1.00 0.0023 0.0023 0.0023












a W2 is mass fraction of alcohols in a water-alcohol binary system free of lanosterol; x / al" 
apb and x / al"van are calculated lanosterol mole fractions by the Apelblat-Jouyban-Acree and 
van’t Hoff-Jouyban-Acree models respectively.
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Table S5. Interaction Parameters for the NRTL and UNIQUAC Models
Solvent
NRTL
A g12 A g 2 i a
Methanol 3786.04 -1893.02 0.20
Ethanol 5866.49 -2933.24 0.20
Isopropanol 5929.32 -2964.66 0.20
w-Propanol 5389.93 -2694.96 0.20
Acetone 4027.24 -2013.62 0.20
Acetonitrile 6080.32 -3040.16 0.20
Ethyl Acetate 3866.78 -1933.39 0.20
Solvent
UNIQUAC







Ethyl Acetate 62.43 -31.22
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Table S6. The Calculated Values for AGmtx Gibbs Free Energy of Mixing,





277.78 -1.19 0.00040 0.0043
288.15 -2.16 0.00072 0.0070
298.15 -3.93 0.0013 0.013
303.05 -4.82 0.0016 0.016
307.55 -5.70 0.0019 0.019
312.15 -7.11 0.0024 0.023
316.95 -9.54 0.0032 0.030
321.65 -14.28 0.0048 0.044
Ethanol
277.95 -14.16 0.013 0.051
285.74 -21.25 0.020 0.074
293.45 -30.10 0.028 0.10
298.25 -37.17 0.035 0.12
302.85 -47.83 0.045 0.15
307.15 -54.82 0.051 0.17
312.35 -68.29 0.064 0.21
318.05 -87.13 0.082 0.27
Isopropanol
278.07 -18.45 0.014 0.066
287.81 -23.84 0.018 0.083
298.84 -38.05 0.029 0.13
307.27 -63.57 0.048 0.21
Table S6. The Calculated Values for AGmtx Gibbs Free Energy of Mixing,





318.93 -92.89 0.069 0.29
w-propanol
278.07 -32.16 0.033 0.12
287.81 -51.60 0.052 0.18
298.84 -75.64 0.076 0.25
307.27 -110.31 0.11 0.36
318.93 -174.39 0.17 0.55
Acetone
278.65 -19.19 0.015 0.070
283.75 -25.20 0.020 0.090
288.45 -30.50 0.024 0.11
293.25 -36.92 0.029 0.13
298.05 -45.56 0.036 0.15
302.75 -55.89 0.044 0.18
307.55 -68.47 0.054 0.22
318.36 -103.74 0.082 0.33
Acetonitrile
277.09 -1.38 -0.00021 0.0050
288.55 -2.80 -0.00041 0.010
293.35 -4.10 -0.00060 0.014
298.15 -5.45 -0.00080 0.018
303.05 -6.75 -0.0010 0.022
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Table S6. The Calculated Values for AGmtx Gibbs Free Energy of Mixing,




307.55 -8.48 -0.0012 0.028
312.25 -11.33 -0.0016 0.036
317.05 -16.49 -0.0024 0.052
Ethyl Acetate
277.67 -21.42 -0.0060 0.077
288.55 -35.80 -0.010 0.12
293.25 -46.22 -0.013 0.16
298.05 -52.65 -0.015 0.18
302.85 -65.88 -0.019 0.22
307.45 -79.45 -0.022 0.26
318.64 -123.16 -0.035 0.39
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Table S7. Solubility of lanosterol (3) in water (l)-methanol (2) binary mixture 
predicted by the Modified Wilson compare with experimental data
296.67 K 306.81 K 316.94 K
RD RD
W2 Xexp̂  xpre3 % XeXp3 Xpre3 RD% XeXp3 Xpre3 %
3.5 1.92 5.95 3.69 1.33
0.0 3E- E- 45.5 E- E- 37.8 E- 6.34 52.
4 09 09 5 09 09 9 08 E-09 17
3.66E 1.58E 6.34E 3.28E 1.51E 6.34E
0.16 -09 -09 56.76 -09 -09 48.17 -08 -09 0.58
3.83E 2.82E 636.1 7.91E 5.84E 638.0 2.06E 1.21E
0.44 -09 -08 5 -09 -08 5 -08 -07 4.90
6.49E 4.95E 662.0 1.01E 9.62E 851.7 1.98E 1.95E
0.65 -08 -07 8 -07 -07 7 -07 -06 8.88
1.30E 1.30E 2.94E 2.32E 5.47E 4.48E
0.88 -05 -05 0.34 -05 -05 21.07 -05 -05 0.18
328.97 K 338.78 K
W2 Xexp3 Xpre3 RD% Xexp3 Xpre3 RD%
3.02E 1.33E 6.56E 2.36E
0.04 -08 -08 56.08 -08 -08 64.03
3.70E 1.55E 7.33E 3.22E
0.16 -08 -08 57.98 -08 -08 56.11
4.72E 3.30E 599.7 1.01E 7.73E 665.9
0.44 -08 -07 4 -07 -07 5
4.74E 5.13E 982.5 1.00E 1.19E 1084.
0.65 -07 -06 9 -06 -05 95
0.000 0.000
0.88 11 11 1.16
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Figure S1. Schematic diagram of the experimental set up: I, water circulating bath; II, 
condenser; III, thermocouple; IV, magnetic stirrers; V, magnetic stirrer controller; VI, 







Figure S2. Total ions chromatogram of purified lanosterol in methanol by GC-MS. The 
retention time of lanosterol is 25.62 minutes and the purity of lanosterol is >95%
m/z
Figure S3. MS scan of lanosterol in methanol at 25.62 minutes. Ion groups (m/z) are 
found as 69,109,393,411 and 426 which indicate by a red circle, respectively. MS scan 
results were compared with data from reference 4 to confirm that the sample is lanosterol
91
Figure S4. van’t Hoff plots of ln(x2) versus 1/T in different solvent. T,methanol; 
0,acetonitrile;A, DMSO; • ,  DMF; ■, ethanol; □ , acetone; V, ethyl acetate; ▲, 
isopropanol; and x , ^-propanol. The solid lines are the solubilities fitted by the modified
Apelblat equation
Figure S5. van’t Hoff plots of ln(xj) versus 1/T in water (1)-methanol (2) mixtures. ♦ ,  
water; ▲, V2=0.050; ▼, V2=0.20; • ,  V2=0.50; □, V2=0.70;and O, V2=0.90. The solid lines 
are the solubilities fitted by the modified Apelblat equation
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Figure S6. van’t Hoff plots of ln(xj) versus 1/T in water (l)-ethanol (2) mixtures. ♦ ,  
water; ■ , V2=0.050; O, V2=0.30; • ,  V2=0.60; □ , V2=0.90. The solid lines are the 
solubilities fitted by the modified Apelblat equation
Figure S7. van’t Hoff plots of ln(xj) versus 1/T in water (l)-isopropanol (2) mixtures. ♦ ,  
water; □  V2=0.050; • ,  V2=0.30; O, V2=0.60;^, V2=0.90. The solid lines are the 
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Figure S8. X-ray diffraction patterns from 2° to 20° 29/ degree of lanosterol powder and 
lanosterol precipitates at equilibrium with lanosterol solutions in pure solvents and water- 
alchol mixtures. A) (a) powder lanosterol before solubility experiments; (b) ethanol; (c) 
isopropanol; (d) w-propanol; (e) DMSO; (f) DMF; (g) actonitrile; (h) methanol; (i) 
acetone; (j) ethyl acetate; (k) water; B) (l) 5%(v/v) ethanol; (m) 90% ethanol; (n) 5% 
methanol; (o) 90% methanol; (p) 5% isopropanol; (q) 90% isopropanol; C) lanosterol 
precipitates at equilibrium with solutions of lanosterol in DMSO and DMF vacuum-oven 
dried 24 hours; (a) lanosterol powder before solubility experiments; (e) wet lanosterol at 
equilibrium with a lanosterol solution in DMSO; (r) dried lanosterol at equilibrium with a 
lanosterol solution in DMSO; (s), dried lanosterol at equilibrium with a lanosterol
solution in DMF
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Figure S9. Differential scanning calorimetry (DSC) of lanosterol from 338.15 K-433.15 
K. The onset Tm is 408.27 K with an uncertainty u(Tm) = 0.50 K; the peak of Tm is 412.39 
K with an uncertainty u(Tm) = 0.60 K; the enthalpy of fusion AHfUs of lanosterol is 23.61 
kJ with an uncertainty u (AH/us) = 0.13kJ-mol-1. DSC experiments were done in triplicate
Figure S10. Differential scanning calorimetry (DSC) of lanosterol after solubility 
measurements. A), dried precipitate at equilibrium with a lanosterol solution in DMSO 
and DMF; B), dried precipitate at equilibrium with a lanosterol solution in ethanol,
isopropanol and w-propanol
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Figure S11. The mole fraction of lanosterol (3), X3, in water and water (l)-methanol (2) 
mixture as a function of temperature. □ , V2=0.70; O, V2=0.90; A, V2=1.00. The insert 
shows X3 in •  , water V2=0.00; ■, V2=0.050; ▲, V2=0.20; ▼, V2=0.50; The solid lines are 
the solubilities fitted by the Apelblat-Jouyban-Acree model and the dash lines are the 
solubilities fitted by van’t Hoff-Jouyban-Acree model
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Figure S12. The mole fraction of lanosterol (3) xj in water and water (l)-ethanol (2) 
mixture as a function of temperature. ▲, V2=0.60; A, V2=0.90; ▼, V2= 1.00. The insert 
shows x3 in :►, water; ■ , V2=0.050; and • ,  V2=0.30. The solid lines are the solubilities 
fitted by the Apelblat-Jouyban-Acree model and the dash lines are the solubilities fitted
by van’t Hoff-Jouyban-Acree model
Figure S13. The mole fraction of lanosterol (3) xj in water and water (1)-isopropanol (2) 
mixtures as a function of temperature. ■ , V2=0.30; O, V2=0.60; • ,  V2=0.90; and ▼, V2= 
1.00. The insert shows x3 in ►, water; and □, V2=0.050. The solid lines are the 
solubilities fitted by the Apelblat-Jouyban-Acree model and the dash lines are the 
solubilities fitted by van’t Hoff-Jouyban-Acree model
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III. IS IT POSSIBLE TO PREVENT AGGREGATION OF ALPHA CRYSTALLIN
BY ADDING STEROLS?
ABSTRACT
Cataract is the main cause of blindness in the world. By age 75, half of the 
Americans will have cataracts according to the National Eye Institute. The only available 
treatment consists of replacing the damaged lenses by artificial ones. Although the 
surgery is safe and it corrects vision problems, not every patient has easy to access to the 
surgery especially in developing countries. In 2015 two reports were published claiming 
that lanosterol (LAN) and 25-hydroxycholesterol (25HD) restored lens’ clarity. Since 
then, there is almost an equal number of publications reporting restoration of lenses 
clarity by lanosterol and 25-hydroxycholesterol as those refuting those findings. There is 
a broader question to be asked: are sterols able to prevent protein aggregation in general? 
Previous studies were all focused on restoring the lenses’ transparency but the effects of 
the two sterols on the a-crystallin aggregation process has not been investigated. In this 
study we showed these two sterols fail to prevent a-crystallin heat induced aggregation. 
Furthermore, sterols at high concentration actually promote a-crystallin aggregation but 
the a-crystallin chaperone activity seems to remain intact. FTIR and CD spectra show 
that the secondary and tertiary structures of a-crystallin does not change significantly in 
the present of the two sterols. Cu2+ binding experiments and bis-ANS hydrophobic 
fluorescent assay further indicate that there is no interactions between a-crystallin and 
those two sterols. Our results show no evidence to support specific interactions between
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a-crystallin and those two sterols and that the lost in chaperone activity is caused by
aggregation of a-crystallin.
1. INTRODUCTION
Cataracts are the main cause of blindness in the world. By age 75, half of the 
Americans have cataracts according to the National Eye Institute.[1] The only available 
treatment presented by previous literature was replacing the damaged lenses by artificial 
ones. Although the surgery is safe and it corrects vision problems, not every patient, 
especially in developing countries, has easy to access to the procedure.[2]
The lens has an onion-like layered structures. Outward facing lens edges have 
mono-layer of epithelial cells that differentiate to new fiber cells during lens development 
over the lifetime of a individual[2]. To maintain lens transparency, fiber cells lack of 
blood vessels and the sub-cellular structures of the fiber cells were removed during 
differentiation^]. Lenses’ high refractive indexes are caused by the high concentration 
of crystallins expressed in fiber cells. Furthermore, only the epithelial cells have 
metabolic activity; therefore, lens fiber cells cannot participate in protein turnover and 
repair.[4] Among lens crystallins, a-crystallin serves as protein chaperone that prevents 
aggregation of other crystallins. The chaperon activity of a-crystallin decreases with age, 
so the lenses lose protection from degradation and oxidation of lens proteins with a 
consequent increase in the scattering of light, thus forming cataracts.[5, 6]
a-crystallin is a hetero-dimer made by aA and aB crystallins that is usually 
present as an oligomer of 10-15 hetero-dimers depending on the conditions.[7, 8] a-
crystallin dimer are connected by two pairs of salt bridges at residues 120R and 109D.
The alpha crystallin domain (ACD), which also involves in the formation of dimer, 
consists of a P-sandwich structure of 6 P-strands. aA and aB crystallin belong to the 
small heat shock protein (sHsp) super family[9]. Members of the sHsp are found in all 
forms of life and have a highly conserved alpha crystallin domain structure across 
species. The sHsps are molecular chaperones that bind to unfolded or partially unfolded 
proteins, preventing their interaction with other unstable proteins. The mini aA crystallin 
is a recombinant peptide of aA crystallin 70-88 segment (mini-aA 70-88 
KFVIFLDVKHFSPEDLTVK), and it shows chaperone activity.[10] The sHsp binds to 
unstable (partly denatured) proteins and prevents them from aggregating, but the 
denatured protein can only be restored to its native state in cooperation with other heat 
shock proteins, such as ATP-driven Hsp70.[11]
In 2015, Zhao et al. [12]and Makley et al.[13] reported that lanosterol (LAN) and 
25-hydroxycholesterol (25HD) restored the lens clarity. They claim those two sterols 
interact with a-crystallin and enhanced the a-crystallin chaperone activity to such an 
extent that the chaperone dissolves or disaggregates lens protein aggregates.
Following the studies of lanosterol and 25-hydroxycholesterol to restore lens’ 
transparency, other researchers tried to repeat those experiments or collect additional 
experimental evidence about the activity of those sterols. The results are mixed. Chen et 
al.[14] showed the lanosterol and 25-hydroxycholesterol in 5% DMSO effectively 
redissolved human cataractous samples ex vivo with a EC50 (Half maximal effective 
concentration) at 10 pM level. They concluded that those two sterols interact with 
crystallins by different mechanisms, aggregates of all members of crystallins could be
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dissolved by lanosterol, but 25-hydroxycholesterol was only specific to a-crystallin, 
which contradicts Makley e ta l.s  findings[13]. Shen et.al.[15] found that, in vitro, 
lanosterol (40 pM in M199 medium) delayed the occurrence of lens opacity in a 
lanosterol synthase inhibited rat lens. Xu et.al.[16] used 20 pM lanosterol in 1% DMSO 
to successfully reverse W151R mutant human pB2-crystallin aggregates. Kang et al. [17] 
used all atom molecular dynamics simulation and free energy perturbation techniques to 
show that lanosterol can bind to the hydrophobic interface of dimers of human yD- 
crystallins preventing aggregation. Yang et al. [18] successfully synthesized a series of 
lanosterol derivatives and reported that a few of them reversed mutant crystallins induced 
protein aggregation. Zhou et al. [19] reported that lanosterol (200 and 500 pM in PBS) 
disrupts the fibrillation of amyloid-P peptides besides redissolving crystallin aggregates. 
They further investigated the interaction of lanosterol and amyloid-P peptides by 
molecular dynamics simulations, and then they concluded that lanosterol entangles with 
the core segment of amyloid-P peptides and forms a hydrophobic core through aromatic 
side chains. Chemerovski-Glikman et al.[20] found that 1 mM 25-hydroxycholesterol in 
10% DMSO PBS but not lanosterol resulted in ~20% reduction of cataract solution (a 
homogenized and resuspended crystallin precipitated) turbidity. Despite the encouraging 
results obtained in in vitro experiments, the clinical trails and the in vivo experiments 
using these two sterols have been unsatisfactory. Felici et.al.[21] reported that using 5 
mM lanosterol in an olive oil eye drop given to patients with idiopathic unilateral juvenile 
nuclear cataracts failed to dissolve cataract or halt the progress of lens opacification. 
Nagai et.al. [22, 23] used lanosterol nanoparticles with a particle size distribution from 50 
to 400 nm to repair the space and structural collapse in the early stages in the lenses.
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They found that it delays the onset of opacification of the lenses with a remarkable lens 
structure collapse and opacification, but it does not repair them. They speculated that the 
repeated injection of lanosterol nanoparticles attenuated the manifestation of cataract- 
related factors and perhaps protects the lenses from oxidative stresses. Shanmugam et 
al.[24] found that 25mM lanosterol in 20% ethanol fails to reverse nuclear opacity of 
human cataractous nuclei after 6 days of incubation. Daszynski et al.[25] failed to repeat 
the experiments by Zhao et al.[12] and Markley et al[13] using their same approach.
Also Daszynkski et al.’s docking simulations shows those two sterols cannot bind to the 
groove which is formed by the a-crystallin dimer using two wild types (PDB 2WJ7 and 
2KLR) and a R120G mutant (PDB 2Y1Z) aB-crystallin.
All efforts were focused on the restoration of cataractous crystallin aggregates, 
but the effects of lanosterol and 25-hydroxycholesterol on the a-crystallin aggregation 
process were not investigated. If the compounds could not avoid protein aggregation, 
they could not solubilize aggregates. Furthermore, the influence of the two sterols on the 
a-crystallin critical biological function and the chaperone activity were not studied. In 
this paper, a series of studies were pursued to evaluate whether or not lanosterol and 25- 
hydroxycholesterol prevented the a-crystallin aggregation and their effects on a native a- 
crystallin chaperon activity using y-crystallin as substrate. a and y-crystallins are highly 
stable at physiological conditions. The melting temperature of bovine a-crystallin and y- 
crystallin is approximately 61oC[26, 27] and 80oC[28, 29], but the turbidity of a- 
crystallin and y-crystallin start to increase at around 65oC and 52oC[29]. a-crystallin starts 
to lose secondary structure at approximately 60 oC[30]. For this study, a-crystallin was 
incubated at 55 oC. The selection of incubation temperatures was based on the following
2) a-crystallin need long periods of time (up to months) to aggregate at temperatures 
below 50oC, making the experiments not practical. Thus, 55oC was selected to be the 
incubation temperature for a-crystallin. Unfortunately, the experiments to evaluate 
chaperon activity happen too fast at 55 oC (within a week). Then, 50 oC was chosen to 
evaluate the a-crystallin chaperone activity because at 50 oC, partially unfolded y- 
crystallin begins to bind to a-crystallin while the secondary structure of a-crystallin is 
maintained.[31, 32]
To better understand the interactions, if any, between a-crystallin and sterols, we 
studied the a-crystallin binding to Cu2+ in the presence of lanosterol and 25- 
hydroxycholesterol. In addition of 4,4'-dianilino-1,1'-binaphthyl-5,5'-disulfonic acid, 
dipotassium salt (bis-ANS) fluorescent assay, we explored the interaction between those 
two sterols and the hydrophobic patches of the a-crystallin. The binding of Cu2+ to a- 
crystallin is critical for a-crystallin. The chaperone activity of a-crystallin has been 
enhanced upon Cu2+ binding[33-35]. The a-crystallin served as a collector of Cu2+ and 
alleviate cytotoxic Cu2+ mediated oxidation[31, 34]. Cu2+ has been reported to bind to a- 
crystallins through the mini-aA 70-88 peptide[36], the a-crystallin chaperone active 
site[10]. The 4-(2-Pyridylazo)resorcinol (PAR) assay has been successfully used to 
measure Cu2+ binding to a-synuclein[37] human aA-crystallin[31]. Therefore, any effect 
of the sterols on the binding of Cu2+ is indirect evidence of them interacting with the a- 
crystallin chaperone activity site. The bis-ANS is a fluoresce probe which binds to 
proteins through interaction with the aromatic rings.[38] Ghahramani et a/.[33], Ghosh
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considerations: 1) Temperatures above 60oC unfold a-crystallin secondary structures,
which changes the potential sterols interaction sites. Therefore, they should be avoided.
et al. [31] and Raju et al. [36] have shown binding of Cu2+ to a-crystallin has lower the 
bis-ANS fluorescence intensity. Raju et al. pointed out the bis-ANS binds to the mini aA- 
crystallin 70-88. And the histamine (H) at position 79 is the binding site for Cu2+.
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2. MATERIALS
Fresh bovine lenses were purchased form Animal Technologies, Inc. (Tyler, TX, 
US) and stored at -20oC in a storage buffer: 1% 2-mercapthanol, 0.245 M acetate buffer 
at pH 5.0. Bulk lanosterol (55% purity), 25-hydroxycholesterol (>98% purity), 4,4'- 
dianilino-1,1'-binaphthyl-5,5'-disulfonic acid, dipotassium salt (bis-ANS) fluorescence 
probe, 4-(2-Pyridylazo)resorcinol (PAR), GC grade dimethyl sulfoxide (DMSO), 
guanidine hydrochloride (GdnHCl) and CuCh were purchased from Sigma-Aldrich (St. 
Louis, MO, US). Cu2+ standard solution was purchased from Acros (Fisher Scientific, 
Hampton, NH, US). Ultrafiltered type 1 water (>18.0 MOhm/cm) was used in all 
experiments. The other chemicals were analytical grade.
3. METHODS
3.1. BOVINE a-AND y-CRYSTALLIN ISOLATION
One bovine lens was thawed in water at room temperature and then homogenized 
in 0.05M Tris pH 7.4 buffer. The homogenate was centrifuged at 15,000 xg at 4oC. The y- 
crystallin was separated from a- and P-crystallin by running the supernatant through a 
Sephadex G-75 gel permeate column (GPC) (2.5 x 60 cm) with 0.05M pH 7.4 Tris buffer
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as mobile phase. The flow rate was 0.5 ml/min, and the Uv detector was set as 280 nm. 
The pooled y-crystallin and the mixture of a- and P-crystallins were dialyzed against 
reverse osmosis (RO) water for 24 hours with water changes every 8 hours at 4oC. After 
dialysis, the samples were lyophilized and stored at -20oC. The a-crystallin fraction was 
separated from P-crystallin with a Sephadex G-200 GPC (2.5 x 60 cm) column using the 
same buffer as mobile phase, but the flow rate was changed to 0.1 ml/min. The a- 
crystallin fraction was dialyzed, lyophilized, and stored at -20oC.
3.2. LANOSTEROL ISOLATION AND 25-HYDROXYCHOLE STEROL
The bulk lanosterol was purified by a method from previous work.[39] Briefly, 
one milliliter of saturated crud lanosterol solution in methanol was injected to an AKTA 
purifier FPLC (Marlborough, MA, US) equipped with C18 reverse-phase column (4.6 
mm x 150 mm). The mobile phase was methanol at a flow rate of 2.0 ml/min. Pure 
lanosterol was collected and then vacuum-oven dried at 60oC. The 25-hydroxycholesterol 
was used as ‘received’ without further purification.
3.3. a-CRYSTALLIN AGGREGATION WITH AND WITHOUT LANOSTEROL 
AND 25-HYDROXYCHOLESTEROL
The following samples were prepared: a-crystallin only, a-crystallin with 5% 
DMSO, a-crystallin with 5% DMSO and lanosterol, a-crystallin with 5% DMSO and 25- 
hydroxycholesterol. The a-crystallin powder was dissolved in 0.1M pH 7.4 phosphate 
buffer at a concentration of 5.0 mg/ml. Lanosterol and 25-hydroxycholesterol were 
dissolved in DMSO at 1.0 mg/ml. Fifty microliters of each sterol stock solutions were 
then mixed with the a-crystallin solution to achieve sterols’ final concentrations of 125
pM in the high concentration sterols experiments. In the low sterol concentration 
experiments, the final sterols concentrations were 0.5 pM and 45 pM for lanosterol and 
25-hydroxycholesterol, respectively. For the control samples, 50 pL of DMSO or 
phosphate buffer were added, instead of the sterol solutions. The samples were 
transferred to the 2 mL polypropylene test tubes with screw caps, and sealed with 
Parafilm M (American National Can, Chicago, IL), and then they were incubated on a 
dry bath at 55oC. The experiments were done in triplicate.
3.4. DYNAMIC LIGHT SCATTERING (DLS)
The particle size distribution of a-crystallin (5.0 mg/ml), lanosterol (0.5pM and 
125pM in 5% DMSO), 25-hydroxycholesterol (45pM or 125pM in 5% DMSO), or a 
mixture of a-crystallin and the two sterols in 0.1M pH 7.4 phosphate buffer were 
measured using fiber optic quasi elastic light scattering (FoQels) (Brookhaven 
Instruments. Holtsville, NY, US). The instrument operated at 25oC. The laser wavelength 
was 830 nm, and the detector had a back angle of 135.9o. The samples were put in a glass 
cylindrical cuvette with a diameter of 1 cm. The correlation function was obtained after 
scanning for 2 minutes, and it fitted with the CONTIN algorithm. The particle size 
distribution were calculated by intensity and by number.
3.5. EVALUATION OF a-CRYSTALLIN CHAPERON ACTIVITY WITH y- 
CRYSTALLIN WITH LANOSTEROL AND 25-HYDROXYCHOLESTEROL
The following samples were prepared: y-crystallin, y-crystallin+ a-crystallin (1:2),
y-crystallin+ a-crystallin (1:2) with 5% DMSO, y-crystallin+ a-crystallin (1:2) with 5%
DMSO and lanosterol, y-crystallin+ a-crystallin (1:2) with 5% DMSO and 25-
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hydroxycholesterol. The a-crystallin and y-crystallin were dissolved in 0.1M pH 7.4 
phosphate buffer at final concentrations of 2.0 mg/ml and 1.0 mg/mL for a-crystallin y- 
crystallin, respectively (a : y 2:1). Fifty microliters of each sterol stock solution was then 
mixed with a-crystallin- y-crystallin solutions to obtain sterols at a final concentration of 
125 pM in the high concentration sterols experiments. In low sterols concentration 
experiments, the final sterol concentrations were 0.5 pM and 45 pM for lanosterol and 
25-hydroxycholesterol, respectively. For control samples, 50 pL of DMSO or phosphate 
buffer were added. The samples were transferred to the 2 mL polypropylene test tubes 
with screw caps, then sealed with Parafilm M and they were incubated on a dry bath at 
50oC. The experiments were done in triplicate.
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3.6. TURBIDITY
The turbidity of the samples was monitored by a Genesys 5 spectrophotometer 
(Thermo Fisher Scientific Inc. Waltham, MA, US) at 600 nm. The temperature was 
controlled by a thermostatic bath at 55oC or 50oC. Samples of 0.8 mL were quickly 
transferred to the polystyrene disposable semi-micro cuvettes with open tops for turbidity 
measurements. Blanks were subtracted and averages calculated. The lag-time, flag, and 
growth-rate, gr, were extracted by fitting the equation[40] below to turbidity data:
F =
F_
(1 + ve-k (f-f” Y v
(1)
where F  is the turbidity at 600nm, Fmax is the maximum turbidity at the steady-state, fm is 
the point of maximum growth rate, and v describes the asymmetry of the sigmoid curve.
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3.7. MONITORING THE SOLUBLE FRACTION BY HPLC
A Shimadzu HPLC system (Nakagyo-ku, Kyoto, Japan) equipped with a Biobasic 
300 size exclusion column was used to monitor the concentration of the soluble fraction. 
The Uv-vis detector was set at 280 nm. The mobile phase was 0.1 M pH 7.4 phosphate 
buffer running at 1.0 ml/min. Samples were first centrifuged at 15,000 xg at 4oC for 5 
minutes, then the supernatant was sampled and diluted. The a-crystallin samples were 
diluted at 12.5x, and a-crystallin + y-crystallin samples were diluted at 5x. Ten pL of the 
samples were injected.
3.8. FOURIER-TRANSFORM INFRARED SPECTROSCOPY (FTIR)
The secondary structure of crystallins was monitored using a Nicolet 6700 FTIR 
(Thermo Fisher Scientific Inc. Waltham, MA, US) spectrophotometer. Before 
measurement, the spectrophotometer was purged with dry air, and liquid nitrogen was 
added to the detector. That was followed by 40 minutes of equilibration. Twenty pL of 
each sample was dried on a CaF2 window using a fan for 5~10 minutes. The CaF2 
window was then put in the measuring chamber. A five minute re-equilibration time was 
given for each time the chamber was opened. The range of 4000 cm-1 to 1000 cm-1 was 
recorded at 64 scan with 8 cm-1 resolution. Amid I peak, 1700 cm-1 to 1600 cm-1 of each 
spectrum was deconvoluted using Origin 2016. The peaks from the deconvolved spectra 
were assigned to specific secondary structures according to previous studies.[42-44]
The growth rate (gr ) is given by k /  (1 + v) and the lag-time (tiag) is calculated from: tm -
(1 + v)/k, which is the time where the tangent at tm crosses the lag-phase baseline.[41]
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3.9. CIRCULAR DICHROISM SPECTROSCOPY (CD)
The 5 mg/ml a-crystallin samples were incubated with 125 ^M of lanosterol or 
25-hydroxycholesterol at 37 oC for 2 hours. Then, they were loaded on a G-75 GPC 
column to remove unbound sterols, using 0.1 M pH 7.4 phosphate buffer as the mobile 
phase and a flow rate of 1 ml/min. The a-crystallin fractions were collected and the 
concentration was measured at 280 nm with an extinction coefficient of A 1% 2 80= 8.42. 
The concentration of a-crystallin was then adjust to 0.3mg/ml for far UV-CD and 2.0 
mg/ml for near UV-CD. The far UV-CD spectra were recorded using a JASCO J-815 
spectropolarimeter (Easton,MD, USA) at 25oC in a 0.2 cm path length quartz cell from 
200 to 250 nm. The near UV-CD spectra were recorded from 250nm to 340nm with same 
instrument, but the protein concentration was changed to 2.0 mg/ml and a 1.0 cm path 
length quartz cell was used. The spectra of proper blanks were subtracted from each 
protein spectrum. The spectra were analyzed using the BeStSel online sever.[45, 46]
3.10. COPPER ION BINDING OF A-CRYSTALLIN IN THE PRESENCE OF 
LANOSTEROL AND 25-HYDROXYCHOLESTEROL, 4-(2-PYRIDYLAZO) 
RESORCINOL (PAR) ASSAY
The PAR assay was adapted from Ghosh et a/.[31] The excess amount of CuCh 
was added to a 0.1 M pH 7.4 phosphate buffer with 5 mg/ml a-crystallin. Then, 50 p,L of 
DMSO or sterols DMSO solution was added to achieve 125 ^M for high concentration of 
those two sterols, 0.5 ^M for low concentration of lanosterol, and 45 ^M for low 
concentration of 25-hydroxycholesterol. After 2 hours of stirring and incubation at 37oC, 
the samples were centrifuged at 1000 xg to sediment the excess amount of CuCh. The 
supernatant was loaded on a Sephadex G-75 GPC (2.5 x 30 cm) column to remove
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unbound Cu2+, using 0.1 M pH 7.4 phosphate buffer as the mobile phase and a flow rate 
of 1 ml/min. The a-crystallin fractions were collected and the concentration was 
measured at 280 nm with an extinction coefficient of A 1% 280= 8.42. Then, the 
supernatant was treated for five minutes with 4M GdnHCl to denature the a-crystallin 
and release the copper ion. After which, 10 pL of a freshly prepared PAR dye solution 
was added to each sample with a final concentration of the dye at 100 pM. The 
absorbance at 514nm was recorded and subtracted from the control sample, which had 
4M GdnHCl and PAR. Cu2+ content was calculated from:
Cu2+ (pM) = 24.33AA514nm + 1.049 (2)
Equation 2 was obtained by measuring a series of Cu2+ standard solution (Acros 
Organics) using PAR.
3.11. BIS-ANS FLUORESCENT ASSAY
The samples were prepared by the same procedures described in the PAR assay. 
The samples after GPC were diluted to 15pM of a-crystallin. That was followed by 
addition of 10 pL of bis-ANS stock solution (14.8 pM in 95% ethanol) to reach a final 
bis-ANS concentration of 0.148 pM. The samples were then incubated at 37oC for 20 
minutes. The bis-ANS fluorescence was monitored using a Nanodrop 3000 
fluorospectrometer (Thermo Fisher Scientific Inc. Waltham, MA, US) with an excitation 
wavelength of 390 nm and the emission spectrum were recorded from 395 nm to 751 nm. 




4.1. DYNAMIC LIGHT SCATTERING
The solubilities of lanosterol and 25-hydroxycholesterol in 5% DMSO are not 
available. First we measured the solubility of the two sterols according to Li and 
Forciniti.[39] They are 0.5 pM for lanosterol and 45 pM for 25-hydroxycholesterol, 
respectively. Therefore, at a concentration of 125 pM (the high sterols samples used in 
this study), the high sterols samples used in this study consist of undissolved sterol at 
equilibrium with a saturated solution. Figures 1 A- D show the particle hydrodynamic 
diameters distribution by number and by intensity of the two sterols at 125 pM in 5% 
DMSO phosphate buffer without a-crystallin. The hydrodynamic diameters calculated by 
number and by intensity were similar. Both sterol “solutions” have large undissolved 
particles. The hydrodynamic diameter of lanosterol and 25-hydroxycholesterol were 
around 1500 nm and 3500 nm. Figures 1 I-L showed the low concentration sterols 
samples with a-crystallin. The hydrodynamic diameters calculated by number and by 
intensity were similar. The only detectable particle is a-crystallin, which has a 
hydrodynamic diameter around 10nm, which was the same of a-crystallin (data not 
shown). Figures 1E - H showed that by adding a-crystallin to high concentration sterols 
solutions, the particle size distributions calculated by number and by intensity were 
different. The particle size distribution calculated by intensity showed that particle 
diameter of undissolved 25-hydroxycholesterol (Figure 1H) decreased to approximately 
600 nm, however, the undissolved lanosterol particle diameter (Figure 1F) barely 
changed. The particle diameter distribution of lanosterol with a-crystallin calculated by
number was approximately 120 nm and for 25-hydroxycholesterol, which was 
approximately 17 nm (Figure 1 E and G). Those results suggested that there were two 
sets of particles in the samples: 1) one set of small particles with a large population that 
correspond to a-crystallin and 2) a set of large particles with a small population that 
corresponds to the undissolved sterols. The hydrodynamic diameter of a-crystallin 
increased upon addition of high concentration of the sterols, which suggests that a- 
crystallin forms large aggregates in the presence of undissolved sterols particles.
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Figure 1. Dynamic light scattering (DLS) of lanosterol and 25-hydroxycholesterol in 5% 
DMSO phosphate buffer 0.1M pH 7.4. Left panel: by number; Right panel: by intensity. 
A and B, 125uM lanosterol. C and D, 125pM 25-hydroxycholesterol. E and F, 5mg/mL 
a-crystallin+ 125pM lanosterol. G and H, 5mg/mL a-crystallin+ 125pM 25- 
hydroxycholesterol. I and J, 5mg/mL a-crystallin+ 0.5pM lanosterol. K and L, 5mg/mL 
a-crystallin+ 45pM 25-hydroxycholesterol
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Figure 2. Turbidity of a-crystallin or a-crystallin and y-crystallin mixture in 0.1M pH 7.2 
phosphate buffer. A, turbidity of a-crystallin incubated with 125pM sterols at 55oC. B, 
turbidity of a-crystallin incubated with 0.5pM lanosterol or 45pM 25-hydroxycholesterol 
at 55 oC. C, turbidity of a-crystallin and y-crystallin incubated with 125pM sterols at 50 
oC. D, turbidity of a-crystallin and y-crystallin incubated with 0.5pM lanosterol or 45pM
25-hydroxycholesterol at 50 oC
Figures 2 C and D show the aggregation kinetics of a-crystallin and y-crystallin 
mixtures. The lag-times and growth rates are summarized in Figure 3 B and D. The 
samples that only had y-crystallin aggregated within half an hour at 50 oC. The samples 
that had a-crystallin yielded longer lag-times and slower growth rates, which 
demonstrated the a-crystallin chaperone activity. Compared to the samples of a-crystallin 
and y-crystallin without DMSO, the samples with 5% DMSO had longer lag-times and
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slower growth rates, which again may be due to the preferential hydration of the protein 
caused by DMSO. The lag-times for the samples with high concentration of both sterols 
decreased drastically, but the growth rates were slower than in the DMSO control. The 
lag-times and growth rates for low sterol concentration samples were not significantly 
different from the DMSO controls.
a-cystallin a-cystallin a-cystallin a-cystallin a-cystallin a-cystallin 
+ 5%DMS0 +5%DMS0 + 5%DMS0 + 5%DMS0 +5%DMS0
+126HMLAN +125jjM 25-HD +0.5pM LAN +45̂ M 25-HO
y-crystallin ,',+a
yta rnt '!+a Y+a T+a
+5% DMSO +5SDMS0 +5% DMSO +5% DMSO +5% DMSO 
+125jiM LAN +125jjM 25-HD +0 5^M LAN +45nM 25-HD
Figure 3.Lag-time and growth rate of a-crystallin or a-crystallin and y-crystallin mixture 
aggregation kinetics. A and C, lag-time and growth rate of a-crystallin. B and D, lag-time 
and growth rate of a-crystallin and y-crystallin mixture
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The soluble fraction of a-crystallin incubated with high concentrations of the two 
sterols was plotted together with turbidity data (Figure 4A). The soluble fraction of a- 
crystallin decreases as the turbidity increases. The soluble fraction of samples without 
DMSO decreases faster than the samples with DMSO as observed in the turbidity 
measurements. The retention times of a-crystallin (Figure 4B) were shorter upon heating, 
which implies that the apparent molecular weight of a-crystallin has increased. The 
increase of a-crystallin apparent molecular weight upon heating has been reported by 
Putilina et.al.[50] who used gel filtration and small angle x-ray scattering (SAXS). That 
increase in the apparent molecular weight a-crystallin may also be the reason for the 
decrease in the soluble fraction at the beginning of heating. The decrease in the soluble 
fraction began at around 24 hrs when the turbidity was still in the lag-phase may reflect 
the lost of soluble aggregates during centrifugation prior to HPLC analysis. At around 
~250 hrs, there is an inverse correlation between the amount of the soluble fraction and 
turbidity values, i.e., the soluble fractions of the sample with DMSO are in the order of 
a-crystallin+ 125gM 25-hydroxycholesterol > a-crystallin > a-crystallin + 125gM 
lanosterol, but the order of for the turbidity values is inversed.
Figure 5A shows that the soluble fraction of a-crystallin incubated with low 
concentration of the two sterols. In this case, the soluble fraction of a-crystallin was not 
significantly different from the control sample (a-crystallin in 5% DMSO). Figure 5B 
shows that the retention times of the a-crystallin were similar to the 5% DMSO control.
Figure 6A-C shows the soluble fraction of the a-crystallin and y-crystallin 
mixtures incubated with high concentration of the sterols. The total soluble fraction
4.2. SOLUBLE FRACTION
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Figure 4. The a-crystallin incubated with 125gM lanosterol or 25-hydroxycholesterol. 1, 
a-crystallin control. 2, a-crystallin 5% DMSO control. 3, a-crystallin+ 125gM lanosterol 
in 5% DMSO. 4, a-crystallin+ 125gM 25-hydroxycholesterol in 5% DMSO. A, soluble 
fraction of a-crystallin. B, retention time of a-crystallin. C, P-sheet content. D, turns and
coil content
Figure 5. The a-crystallin incubated with 0.5gM lanosterol or 45gM 25- 
hydroxycholesterol. 1, a-crystallin control. 2, a-crystallin 5% DMSO control. 3, a- 
crystallin+ 0.5gM lanosterol in 5% DMSO. 4, a-crystallin+ 45gM 25-hydroxycholesterol 
in 5% DMSO. A, soluble fraction of a-crystallin. B, retention time of a-crystallin. C, P-
sheet content. D, turns and coil content
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Figure 6. The a-crystallin and y-crystallin mixture incubated with 125gM lanosterol or 
25-hydroxycholesterol. 1, y-crystallin. 2, a-crystallin and y-crystallin mixture (2:1) 
control. 3, a-crystallin and y-crystallin mixture (2:1) 5% DMSO control. 4, a-crystallin 
and y-crystallin mixture (2:1)+ 125gM lanosterol in 5% DMSO. 5, a-crystallin and y- 
crystallin mixture (2:1)+ 125gM 25-hydroxycholesterol in 5% DMSO. A, total soluble 
fraction. B a-crystallin soluble fraction. C, y-crystallin soluble fraction. D, retention time 
of a-crystallin. E, P-sheet content. F, turns and coil content
includes both soluble a-crystallin and y-crystallin, and it decreased as the turbidity 
increases (Figure 6A). The soluble fraction data are compared against turbidity in Figures 
6B and C. The y-crystallin soluble fraction drastically decreases within 50 hours, but the 
turbidity of the samples with a-crystallin is still in the lag phase, which demonstrates a- 
crystallin chaperone activity. Putilina and co-workers[50] also showed that a-crystallin 




























the samples with 5% DMSO than the samples without DMSO (Figure 6C); i.e., at 
approximately 50 hours, the a+y without DMSO had around 50% y-crystallin soluble 
fraction and the samples with DMSO had around 30% y-crystallin soluble fraction. 
Therefore, DMSO promotes unfolding of the y-crystallin. The unfold y-crystallin bound 
to a-crystallin to form a/y complex within 9 hours at 55 oC.31 Therefore, the soluble 
fraction of a-crystallin included a-crystallin and a/y complex. In Figure 6C, the soluble 
fraction of y-crystallin with high concentration of sterols decreased to 30% within 50 
hours. The turbidity is also increased but not to the extent of the samples containing only 
y-crystallin. Figure 6B shows that the a-crystallin soluble fraction also decreased in the 
samples containing high concentrations of sterols. Therefore, the increase in turbidity is 
mainly caused by the loss of a-crystallin or the a/y complex. Compared to the a-crystallin 
turbidity data, the a/y complex has a higher aggregation propensity. In spite of the fact 
that a-crystallin was incubated at higher temperatures (55oC vs 50oC) and higher 
concentrations (5 mg/mL vs 3 mg/mL). Figure 6D shows that the retention time of a- 
crystallin first decreases to a minimum, and then increased. The decrease in a-crystallin 
retention time indicates that the apparent molecular weight of a-crystallin increases by 
forming higher oligomers and by binding to unfolded y-crystallin.[50] The minimum 
retention time appeared at the end of the growth phase of each sample. It indicated there 
was remaining soluble low molecular weight a-crystallin in the solution.
Figure 7A-C show the soluble fraction of a-crystallin and y-crystallin incubated 
with low concentration of lanosterol or 25-hydroxycholesterol. Figure 7D shows the 
retention time of a-crystallin vs incubation time. No major differences were found 


















Figure 7. The a-crystallin and y-crystallin mixture incubated with 0.5gM lanosterol or 
45gM 25-hydroxycholesterol. 1, y-crystallin. 2, a-crystallin and y-crystallin mixture (2:1) 
control. 3, a-crystallin and y-crystallin mixture (2:1) 5% DMSO control. 4, a-crystallin 
and y-crystallin mixture (2:1)+ 0.5gM lanosterol in 5% DMSO. 5, a-crystallin and y- 
crystallin mixture (2:1)+ 45gM 25-hydroxycholesterol in 5% DMSO. A, total soluble 
fraction. B a-crystallin soluble fraction. C, y-crystallin soluble fraction. D, retention time 









































4.3. SECONDARY STRUCTURES MONITORED BY FTIR
The protein secondary structures were monitored by FTIR through the 
aggregation processes. The Amide I peaks were deconvoluted. Figure 8 shows an 
example of the deconvolution of the Amide I peak, which were at the beginning and at 
the end of the a-crystallin that was incubated with 125 pM lanosterol at 55oC. The 
deconvoluted peaks were assigned to the following secondary structures: 1630 and 1691 
cm-1 are P-sheet, 1641 cm-1 is a-helix, 1661 cm-1 is turns and 1676 cm-1is random 
coil.[42-44] The area percentages for each deconvoluted peak were used to represent the 
content of each secondary structure.
Figure 8. Examples of FTIR Amid I spectra deconvolution. The red lines are second 
derivative of Amid I peak. The black slid line is the sums of the deconvoluted peaks, and 
the dash line represent the deconvoluted peaks. The peaks are: 1630 and 1691 cm-1 are P- 
sheet, 1641 cm-1 is a-helix, 1661 and 1676 cm-1 are turns and random coil. A, a-crystallin 
+ 125pM lanosterol before incubated at 55oC. B, a-crystallin + 125pM lanosterol
incubated at 55oC for 460 hours
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Figure 4 C and D and Figure 5 C and D show the percentages of P-sheet and turns 
and coil of a-crystallin vs incubation time. The native a-crystallin secondary structure 
contents were a-helix: 15%, P-sheet: 45% and turns and random coil: 40%, which agree 
with previous publications.[30, 47] The P-sheet decreased slightly from 45% to 42% 
during the incubation. The percentages of the turns and random coil increased from 39% 
to 42%. The a-helix stayed at approximately 15% throughout incubation. No significant 
changes to the secondary structure of a-crystallin at 55oC were expected because 
previous tests showed the significantly loss of a-crystallin secondary structures usually 
been seen above 60oC.[30] The changes to a-crystallin secondary structure of the samples 
containing both sterols were similar to the DMSO controls, regardless of high or low 
sterol concentration.
Figure 6 E and F and Figure 7 E and F show P-sheet and turns and random coil 
percentages verse incubation time of a-crystallin and y-crystallin samples. The 
deconvoluted peaks of native y-crystallin were: 1638 cm-1 and 1690 cm-1 (P-sheet, 58%), 
1661 cm-1 (a-helix 20%) and 1675 cm-1 (turns 21%). The secondary structure contents of 
the y-crystallin measured in this study were similar to previous publication.[48] After 
incubating for 24 hours, a set of new peaks were found: 1618 and 1634 were assigned to 
P-sheet (30%), 1651 was assigned to random coil (32%), 1670 and 1682 were assigned to 
turns (39%). At the end of incubation (260 hours), the a-helix of y-crystallin was 
completely lost, the percentage of P-sheet content was reduced to 22%, and the turns and 
coil contents were raised to 78%. In the samples containing both a-crystallin and y- 
crystallin, the infrared signal was a combination of both crystallins. The P-sheet content 
was reduced from 47% to 38%, and the turns and coil contents were increased from 39%
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to 46%; the a-helix still held at approximately 15%. This study argued that these changes 
were caused by the unfolding of gamma-crystallin. The secondary structure contents of a- 
crystallin and y-crystallin had no significant differences between the samples containing 
lanosterol and 25-hydroxycholesterol and the DMSO controls.
4.4. Cu2+ CONTENT OF a-CRYSTALLIN
Figure 9 shows the Cu2+ content of a-crystallin with and without the two sterols 
measured by PAR assay. The a-crystallin isolated for this study in the lab had no Cu2+ 
content (data not shown). Figure 9 shows that neither high nor low concentrations of the 
two sterols had effect on the Cu2+ binding capacity of a-crystallin. The a-crystallin bound 
to Cu2+ at a ratio of 1:3, which was lower than the mini aA-crystallin 70-88 that bound to 
Cu2+ at a ratio of 1:1 [36], and the recombined human aA-crystallin bound at (1:2).[31] 
The Cu2+ binding capacity of a-crystallin oligomers is lower than the one for the mini 
aA-crystallin monomer,[36] and the one for recombinant aA-crystallin since the 
recombinant protein forms oligomers of different size.[49] And the incubation time and 
temperature may affect the binding. The mini aA-crystallin incubated with Cu2+ for 30 
minutes at 25 oC and recombinant aA-crystallin incubated with Cu2+ for 9 hours at 55 oC.
Figure 10A shows the fluorescence spectra of bis-ANS. The fluorescence 
intensity of 490nm of each sample is summarized in Figure 10B. The results were sorted 
into two groups: with Cu2+ and without Cu2+. Adding Cu2+ lowered the bis-ANS 
fluorescence intensity.The mini aA-crystallin region 70-88 
KFVIFLDVKHFSPEDLTVK bound Cu2+ through 79 His[36] that was negatively 
charged at pH 7.4. The 71 Phe, 74 Phe and 80 Phe may interact with bis-ANS through the
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aromatic side chains[38]. The Cu2+ and bis-ANS probe competed for the binding 
sites[36]. The lanosterol and 25-hydroxycholesterol had no significant effect on the bis- 
ANS fluoresce intensity, regardless of high or low sterol concentration.
a-crystallin a-crystallin a-crystallin a-crystallin a-crystallin a  crystallin
+DMSO +DMSO +DMSO +DMSO +DMSO
+ 125|.iM +0.5 mM +125|.iM +45 jiM
LAN LAN 25-HD 25-HD
Figure 9. The Cu2+ content of a-crystallin. The a-crystallin incubated with access amount 
of Cu2+, then separated by GPC. The Cu2+ content was measured by PAR assay. 25-HD
represent the 25-hydroxycholesterol
4.5. CIRCULAR DICHROISM
To corroborate the FTIR-based protein secondary structures, far-Uv CD 
measurements were used (Figure 11). The a-crystallin incubated with 125pM lanosterol 
or with 25-hydroxycholesterol was loaded on a G-75 GPC to remove particles that 
interfered with the CD measurements. As shown in the Figure 11B, the secondary 
structures of samples incubated with sterols and of DMSO control samples showed no 
significant differences. Therefore, the secondary structure contents were similar to the 
results of FTIR. In the near-Uv CD spectra, shown in Figure 12. The tertiary structure of
the samples with the two sterols had no significant difference compared to the DMSO
control samples.
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Figure 10. bis-ANS fluorescence spectra of a-crystallin. A, bis-ANS fluorescence spectra 
of 15pM a-crystallin. The a-crystallin incubated with sterols or controls for 2 hours then 
separated by GPC. The blank of 30pM bis-ANS in phosphate buffer was subtracted. B,
the fluoresce intensity at 490 nm
125
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Figure 11. Far-UV CD spectra of the a-crystallin after GPC. A, Far-UV CD spectra. B, 
secondary structure of a-crystallin which are analyzed by BeStSel online sever.[45]




a-crystallin has internal cavity structures,[50, 51] which may trap small 
molecules,[52] such as dexamethasone,[52] 1-anilinonaphthalene-8-sulfonic acid 
(ANS)[53] and acrylamide.[54] Augusteyn et a/.[52] concluded that this phenomenon 
was a nonspecific partitioning. By analogy, the solubilization of 25-hydroxycholesterol 
by a-crystallin was reported by Puttur et a/.,[25] who explained the solubilization by 
speculating that 25-hydroxycholesterol was trapped by a-crystallin oligomers, but not 
lanosterol. It is not known why lanosterol does not partition into the same cavities. Our 
DLS measurements show that the undissolved particle size of 25-hydroxycholesterol was 
reduced from 3500 nm to 600 nm by adding a-crystallin (Figures 1 D and H). On the 
contrary, the undissolved particle size of lanosterol was not significantly affected by the 
addition of the a-crystallin (Figures 1 B and F). Therefore, reduction of the undissolved 
25-hydroxycholesterol particle size may be due to the nonspecific partitioning whereas 
lanosterol does not partitioned in agreement with Puttur et aTs hypothesis.
Lanosterol and 25-hydroxycholesterol failed to prevent a-crystallin aggregation. 
Moreover, at sterol concentrations of 125 pM, a-crystallin aggregation was promoted.
The turbidity of a-crystallin incubated with low concentration of the two sterols, showing 
that the sterols do not change the aggregation kinetics. The a-crystallin chaperone activity 
was not affected by low concentrations of the two sterols. This indicated that completely 
dissolved lanosterol or 25-hydroxycholesterol did not interact with a-crystallin. In the 
turbidity data with high concentration of lanosterol or 25-hydroxycholesterol, the lag- 
times were shorter than the DMSO control samples, which implied that the solid sterol
particles served as nucleation sites. Based on the DLS measurements, the solutions 
containing high concentration sterols had large undissolved particles that may have 
affected the aggregation kinetics.
The a-crystallin chaperone activity was evaluated by using y-crystallin as 
substrate. The lag-times for a+ y-crystallin samples with high concentration of the two 
sterols were shorter than the time yielded by the DMSO control. The undissolved sterol 
particles altered the aggregation kinetics. Figure 6B and C show that the increase in 
turbidity was caused by a/y complex or a-crystallin precipitation. Because the turbidity of 
the high concentration sterols samples did not increase as fast as the y-crystallin control 
samples, so it was concluded that increase in turbidity was due to decreases in the soluble 
fraction of a-crystallin and a/y complex. The two sterols promoted the aggregation of a/y 
complex and a-crystallin. The chaperone activity of a-crystallin was not affected by the 
lanosterol or 25-hydroxycholesterol. This conclusion was further supported by the PAR 
and bis-ANS assay that the chaperone activity sites were not affected by the two sterols, 
regardless of high or low concentrations of the two sterols.
The a-crystallin samples incubated with high concentration of the two sterols 
were selected to be assessed by CD measurements because high concentration of sterols 
changed the aggregation kinetics. The 125 pM of lanosterol or 25-hydroxycholesterol did 
not change the secondary structures of a-crystallin, which was confirmed by far UV-CD 
and FTIR. The near UV-CD spectra showed that the tertiary structures of a-crystallin 
were not affected by high concentration of the two sterols either.
The PAR assay showed the Cu2+ content of a-crystallin was not affected 
regardless of the sterol concentration used. Therefore, the chaperone binding sites of
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alpha-crystallin were not occupied by the sterols. However, the binding to other sites 
cannot be excluded, but that can be addressed by looking at the bis-ANS assays. The bis- 
ANS bound to hydrophobic sites on the a-crystallin that included the Cu2+ binding site. 
The bis-ANS fluorescence intensity of samples incubated with Cu2+ was not affected by 
the two sterols. That confirmed the result of the PAR assay that stated that the two sterols 
did not affect the Cu2+ binding capacity of a-crystallin. The bis-ANS fluorescence 
intensity of the samples incubated without Cu2+ was not affected by the two sterols in any 
concentration. It can be stated that the sterols did not bind to the chaperone site. The bis- 
ANS and the Cu2+ competed for the chaperone binding site, which was the mini aA- 
crystallin region. The affinity of bis-ANS was weaker than that of Cu2+. The possibility 
of the sterols having weaker interactions than the bis-ANS with the chaperone binding 
site was not ruled out by this study.
The a-crystallin dimer interface was another potential binding site for sterols 
beyond the chaperone binding site. Makley et al. [13] and Daszynski et al. [25] studied the 
possible interactions between 25-hydroxycholesterol or lanosterol and the a-crystallin 
dimer interface by docking simulations. Both of them predicted the Kd (dissociation 
constant that is the ligand concentration at which half the protein molecules will have a 
ligand bound) of the two sterols were in the high micromolar or even millimolar range; 
i.e. Kd values for lanosterol-2KLR (wildtype aB-crystallin) and 25-hydroxycholesterol 
dimer interface were 73.63 mM 25-hydroxycholesterol and 1.22 mM, respectively.[25] 
Daszynski et al. [25] concluded that this high concentration of the two sterols could not be 
achieved clinically in the lens. Based the experimental results of this study and the 
conclusion from Daszynski et al., the interactions, if any, between lanosterol or 25-
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hydroxycholesterol and a-crystallin are not specific. The presence of undissolved sterols 
particles that served as aggregation nuclei may be the reason that the undissolved sterols 
promoted a-crystallin and a/y complex aggregation.
6. CONCLUSIONS
In this study, it was found that lanosterol and 25-hydroxycholesterol failed to 
prevent a-crystallin aggregation induced by heating. Sterol concentration of 125pM 
promoted the aggregation of a-crystallin and of the a/y complex possibly by serving as 
nucleation sites. The chaperone activity of a-crystallin was not affected by the two 
sterols, which suggested that the sterols did not bind to the chaperone binding site. This 
was confirmed by the bis-ANS results. FTIR and far-UV CD analysis showed that the 
secondary and tertiary structures of a-crystallin were not affected by the presence of the 
two sterols, regardless of their concentrations. Furthermore, the two sterols had no 
significant effect on the Cu2+ or on the bis-ANS binding capacity of a-crystallin. 
Therefore, hydrophobic sites were not interaction sites for the two sterols and a- 
crystallin. Thus, no evidence was been found that the two sterols interacted specifically 
with the a-crystallin.
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2. CONCLUSIONS AND FUTURE WORK
2.1. CONCLUSIONS
This dissertation covers a range of topics all related directly or indirectly to 
protein solubility and its consequences during the processing of proteins or in human 
health. A considerable effort was put in a supportive study (solubility of sterols) because 
the data was needed to better understand the effect of sterols in protein solubility. The 
main conclusions of this work as summarized in the following paragraphs.
In paper I, glycosylated and non-glycosylated mAbs were precipitated by PEG. 
Effects of PEG molecular weight, pH, and temperature were studied. The glycosylated 
mAbs had higher solubility than non-glycosylated mAbs in all conditions. Although 
glycosylation increases the molecular weight of mAbs the glycosylated mAbs required 
higher amounts of PEG to precipitate, which contradicts the predictions of excluded 
volume theory. Glycosylation had major effects on the PEG precipitation efficiency but 
not on the onset precipitation point. The lectin and mAbs were found to form a hetero­
complex at several pH levels due to electrostatic attractions. A few solubility models used 
in this work were not able to explain the effect of glycosylation or protein solubility.
In paper II, the solubility of lanosterol in organic solvents and water-alcohol 
binary systems was measured at different temperatures. The activity coefficient models of 
Wilson, NRTL and UNIQUAC correlated the experimental data satisfactorily. The 
Apelblat -Jouyban-Acree and the van’t Hoff-Jouyban-Acree models correlated water-
alcohol binary systems without significant deviations. The lanosterol solubility data 
collected in this paper showed that the lanosterol concentration used in crystallins 
aggregates restoration experiments was exceeded the solubility limit of the sterol.
In paper III, it was found that lanosterol and 25-hydroxycholesterol failed to 
prevent a-crystallin aggregation upon heating. A concentration of 125pM of the two 
sterols promoted the aggregation of a-crystallin and of the a/y complex possible by 
serving as nucleation sites. The chaperone activity of a-crystallin was not affected by the 
two sterols, which suggest that the sterols do not bind to the chaperone binding site. This 
was confirmed by the bis-ANS results. FTIR and far-UV CD revealed that the secondary 
and tertiary structures of a-crystallin were not affected in the presence of the two sterols 
regardless of concentration. Furthermore, those two sterols had no significant effect on 
the Cu2+ binding capacity of a-crystallin. The hydrophobic sites were not the interaction 
sites for those two sterols and the a-crystallin. Thus, no evidence was found that those 
two sterols interacted with the a-crystallin specifically.
2.2. FUTURE WORK
In this dissertation, several questions were answered but more issues arose as the 
consequence of this work. The role of glycosylation in protein precipitation by PEG was 
clarified in the work, but the result was restricted to mAbs. More glycosylated proteins 
and their non-glycosylated counterparts need to be considered. Then the effect of 
glycosylation can be added to PEG precipitation models quantitatively. Moreover, 
pegylation is a popular protein modification that uses PEG instead of glycans to
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covalently attach to protein molecules. Then the role of pegylation in the PEG 
precipitation may be investigated.
In paper II, we collected lanosterol solubility data. As shown in the sterols 
restoration of cataract patterns, there are more sterols with restoration capabilities. The 
solubility data of a few sterols in that pattern are still unavailable. The missing solubility 
data is an obstacle to further study of those sterols. The future work should generate more 
solubility data of sterols.
Publications reported the failure of lanosterol to restore lenses’ transparencies 
during the course of this dissertation. During the same time, more compounds were 
discovered to dissolve crystallin aggregates.[43, 44] The mechanism behind this 
phenomenon was still unclear. The methods used for this dissertation yielded information 
about the sterols’ effects on the crystallin aggregation. Those methods could be extended 
to other compounds besides lanosterol and 25-hydroxycholesterol.
Senile cataract was used as a target in sterols restoration experiments. Over the 
lifetime of an individual, crystallins are subjected to a wide range of post-translational 
modifications that reduced their stabilities and promoted aggregations. [29] Truncation, 
deamidation, racemisation, oxidation, and methylation are common post-translational 
modifications that appear in cataract-affected eye lenses. In this dissertation, it showed 
that the two sterols did not interact with a-crystallin specifically. To better understand the 
interaction between sterols and senile cataract lenses, the aggregation processes of 
degraded crystallins should be tested with lanosterol and 25-hydroxycholesterol 
individually.
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Even though the mechanism of crystallin aggregation dissolved by sterols was 
unclear, it is a reasonable assumption that sterols may dissolve other protein aggregates. 
Cataract development is not the only disease caused by the protein aggregation. 
Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral 
sclerosis, and prion diseases are all associated to protein aggregates.[45] The exploratory 
study done by Zhou et al. [46] showed that lanosterol disrupted the aggregation of 
amyloid-P Peptides, which is associated with Alzheimer's disease. The effects of the 
sterols were not limited to lanosterol and 25-hydroxycholesterol on those disease-related 
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